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ABSTRACT

ARTEMIS AND METNASE MEDIATED PROCESSING OF 3΄-BLOCKED DNA LESIONS:
ROLE IN RADIO/CHEMORESISTANCE AND DNA REPAIR
By Susovan Mohapatra, B.Pharm.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2012
Advisor: Lawrence F. Povirk, Ph.D. Professor, Department of Pharmacology and Toxicology
DNA double-strand breaks (DSB) with chemically modified end-termini are the most
significant lesions resulting from radio/chemotherapeutic intervention of cancer and
non-homologous end-joining (NHEJ) factor Artemis nuclease has been implicated in the repair
of such breaks. To examine whether the resolution of terminally blocked DNA DSBs is the
biologically relevant function of Artemis, Artemis deficient fibroblasts were stably
complemented with wild type or an endonuclease deficient D165N mutant Artemis.
Physiological levels of wild type (WT) Artemis completely restored DSB repair proficiency and
resistance to γ-radiation, bleomycin, and neocarzinostatin. Cells expressing the D165N mutants
remained as chemo/radiosensitive and as repair deficient as parental cells, with persistent
γ-H2AX and 53BP1 foci that increased in size 6-18 hour post irradiation. These persistent foci
co-localized with DNA double strand break repair factor Mre11 and also with promyelocytic
leukemia protein (PML). Further, in vitro studies have revealed that DNA-PK dependent Artemis

xv

endonucleolytic activity may play a role in the repair of commonly found oxidative base damage;
8-oxoguanine (8-oxoG), a hallmark of complex DSBs.
However, majority of DNA DSBs are repaired in an Artemis independent manner, and recently
discovered, DNA end-specific nuclease, Metnase is a candidate enzyme for repair of such
breaks. To study the role of Metnase in resolution of 3ʹ-blocked termini, several substrates
mimicking such breaks were constructed. A 3ʹ-phosphoglycolate moiety on longer overhangs (4
and 6 bases) altered specificity and stimulated Metnase-mediated cleavage of the terminal
3 nucleotides. However, an 8-oxoG residue at the single-strand/double-strand border did not
affect specificity or extent of cleavage. Metnase preferentially cleaved ssDNA-overhang of a
partially duplex substrate, and the cleavage increased with increase in length of 3ʹ-overhangs. A
D483A mutation in Metnase completely abrogated Metnase cleavage activity towards DNA
ends.
These results suggest that Metnase may resolve oxidatively damaged DNA ends to facilitate
repair while Artemis is required for the resolution of more complex DNA DSBs that persist for
longer times and are not amenable to repair by other NHEJ factors.

I.

GENERAL INTRODUCTION

According to the National Cancer Institute’s Surveillance Epidemiology and End Results
(SEER) approximately 1,596,670 people were estimated to be diagnosed with cancer in 2011 and
571,950 of those diagnosed were predicted to die in United States alone. On January 1, 2008
approximately 11.9 million people in the United States were alive with a history of cancer.
About seventy-five percent of these patients may receive radiotherapy sometime during the
course of their disease (Tofilon, Camphausen 2009).
Radiation therapy has been used for the treatment of cancer for more than 100 years. The
first claimed treatment involving X-rays occurred on January 29, 1896, which was three months
after the announced discovery of X-rays by Wilhelm Roentgen (Orton 1986), when a medical
student in Chicago treated advanced breast carcinoma in a patient using X-ray tubes.
Though radiation therapy has become one of the mainstays for treatment of cancer since, it is
also a proven human carcinogen. Even today therapy-induced secondary cancers make up an
astonishing 1/6th of all new diagnosed cancers in the US alone.
Both the therapeutic and carcinogenic effect of radiation is believed to result mainly from its
interaction with DNA.
1.1 Structure of DNA
Until 1953, nucleic acids were not considered very important. At the time, protein rather
than DNA was considered by most scientists as the carrier of genetic information. Following the
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discovery of protein structure by Linus Pauling and Robert Corey in the April of 1951 published
as seven back to back articles in PNAS (Pauling, Corey 1951a, Pauling, Corey 1951g, Pauling,
Corey 1951b, Pauling, Corey 1951d, Pauling, Corey 1951f, Pauling, Corey 1951e, Pauling,
Corey 1951c), the next big question that remained unanswered was the discovery of the structure
of nucleic acids.
Subsequently, Pauling and Corey concentrated their efforts on deciphering the structure of
DNA. However, they had insufficient data to deduce the structure correctly. Using a few blurry
X-ray patterns published by William Astbury in 1947, Pauling decided that DNA was a three
chain helix, with the bases facing outward and the phosphates in the core. He published his
results in 1953 in PNAS. Shortly after, Pauling’s article was published in Feb 1953; it became
apparent that Pauling’s structure was not correct.
The correct structure of DNA was solved by Watson and Crick who published their results
in Nature on April 25, 1953 (Watson, Crick 1953). However, their work was made possible due
to the contributions of Rosalind Franklin (Franklin, Gosling 2003), who created the world’s best
X-ray diffraction pictures of DNA and Maurice Wilkins (Wilkins, Stokes & Wilson 1953), who
was also working at Kings College, London.
The structure of DNA as described by Watson and Crick has two helical chains coiled
around the same axis. Both chains follow right handed helical pattern, and are antiparallel. The
bases are on the inside and the phosphates on the outside. The deoxyribose sugar is roughly
perpendicular to the attached base. There is a residue on each chain every 3.4 Å, and the
structure repeated itself after 10 residues or 34 Å. The distance of the phosphorous from fiber
axis is 10 Å, and as the phosphates are on the outside they have easy access to cations. A purine
on one chain is hydrogen bonded to a pyrimidine on the other chain. The bases occur in the
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structure as the keto form with Adenine (Purine) bonding with Thymidine (Pyrimidine) and
Guanine (Purine) bonding with Cytosine (Pyrimidine). For their accurate description of the
structure of DNA, James Watson and Francis Crick along with Maurice Wilkins were awarded
the Nobel Prize in Physiology and Medicine in 1962.

1.2 Types of DNA lesions
Initially it was assumed that, since heredity is a stable process, the fundamental structure
of DNA itself was stable and not subject to frequent alterations. However, looking at the double
helical chemical structure of DNA, it becomes immediately apparent that DNA may continually
react with oxygen and water, resulting in multiple DNA lesions. Such lesions may be broadly
classified as endogenous and environmental. Endogenous DNA damage may result from
intracellular production of reactive oxygen species (ROS), from normal cellular metabolism,
V(D)J recombination and stalled DNA replication forks. The main types of DNA damage
resulting from endogenous cellular processes are oxidation of bases (e.g. 8-oxoguanine),
alkylation of bases (e.g. 7-methylguanine), hydrolysis of bases (deamination, depurination,
depyrimidination), bulky adduct formation and mismatch of bases (due to errors in replication)
(De Bont, van Larebeke 2004).
Exogenous DNA damage can occur due to exposure to ultraviolet light (UV-B light
causes crosslinking creating pyrimidine dimers, UV-A light creates mostly free radicals),
industrial chemicals (Polycyclic hydrocarbons like benzo-(a)-pyrene may cause DNA bulky
adducts) or due to therapeutic exposure to ionizing radiation (oxidation of bases, single-strand
breaks and double-strand breaks).
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1.3 Mechanism of DNA double strand break induction by ionizing radiation
DNA is the critical target for radiation and most biological effects of radiation result
mainly from damage to DNA (Hutchinson 1966). High-LET radiation (Linear Energy Transfer)
like α-particles or neutrons interact directly with critical biomolecules in cells ionizing atoms of
the target itself. However, radiation may interact with other molecules in the cell (water) to
produce free radicals that may damage critical targets within their diffusion distance (Mozumder
and Magee 1966). The initial radical production following energy deposition is non-homogenous,
and high local concentrations occur in events called spurs (6-100eV for 1MeV electron) and
blobs (100-500eV for 1MeV electron) (Schwarz 1969) (Mozumder 1985). The initial size of
these pockets of energy deposition was estimated to be 17 Å (DNA radius is 10 Å). Since the
energies deposited in these small volumes are much larger than the energies of chemical bonds
(4-5eV) (Mozumder 1985), these small pockets inside the cell represent high radical ion
concentrations. It is also clear that the interstrand distance (10 Å) can be spanned by regions of
high radical density, making multiple radical attacks on opposite strands possible. These radical
attacks in close proximity on both strands can lead to locally multiply damaged sites (Complex
DNA damage) (Ward 1990), that may include DNA double-strand breaks (DSB), along with
accompanying base damage like 8-oxoguanine and thymidine glycol as well as single strand
breaks (SSB) (Demple, Harrison 1994b). SSBs and DSBs are produced in different proportions.
While there are 1000 SSBs estimated for a Gy of radiation, about 40 DSBs occur per cell per Gy
(Ward 1990). DNA DSBs are thought to be the most important lesion for cell killing. Hence, it
is extremely important to understand the various DNA damage responses that have evolved in
cells to repair this damage, because even a single unrepaired
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Figure 1-1. Types of DNA damage following irradiation. Radiation directly interacts with
water, which constitutes 80% of the cell volume, to form hydroxyl radicals (OH.) that then
account for the majority of the damage caused by γ-rays. The hydroxyl radical in aqueous
solution then diffuses and damages lipid membranes, proteins and DNA. The proximity of the
free radical generation to DNA, diffusion distance and the energy of the radical are some of the
factors that are determinant of the type of damage (double-strand breaks, single-strand breaks or
base damage) generated.
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DNA DSB can lead to cell death.

1.4 DNA Damage Responses
DNA DSBs constitute one of the most severe forms of DNA damage. Incorrectly repaired
DSBs can lead to deletions, inversions, translocations, chromosome fusions and chromosome
loss, which can result in cell death or transformation, further leading to oncogenesis (Elliott,
Richardson & Jasin 2005, Jasin 2000, Thompson, Schild 2001, Thompson, Schild 1999).
However, cells have multiple redundant pathways to appropriately respond to such insult.
The first step in a cell’s response to any form of DNA damage including DNA DSBs is to
recognize the presence of damage. The mechanism governing the recognition of DNA DSBs and
repair pathway choice still remains unresolved.
According to one hypothesis, phosphorylation of γ-H2AX along with changes in
chromatin structure activates ATM (Ataxia Telangiectasia Mutated), which is the main DNA
damage sensor (Abraham 2001, Durocher, Jackson 2001). MRN (Mre11/Rad50/Nbs1) complex
is also one of the first proteins that recruits and binds to broken DNA ends. It has also been
shown to promote the recruitment and activation of ATM through an ATM interaction motif
within the C-terminal of Nbs1 (Uziel et al. 2003, Lee, Paull 2004). Activation of ATM leads to
its monomerization (Inactive ATM is present as dimers or multimers). Activated ATM further
phosphorylates H2AX on the C-terminal tail at Ser139, over megabase regions surrounding a
DSB, within 1 minute of damage and reaches peak levels by 20 minutes (Rogakou et al. 1998)
(Burma et al. 2001). Many DNA damage response proteins are then recruited to the sites of DNA
DSBs to form IRIF (Ionizing radiation induced foci). Early IRIF are shown to consist of γ-H2AX,
53BP1, MRN complex and MDC1, that reach peak levels at the IRIF within 30 min (Rogakou et
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al. 1998, Schultz et al. 2000) (Stewart et al. 2003). Rad51, Rad52, BRCA1 and BRCA2 do not
form foci until later times following IR exposure. ATM along with BRCA1, the mismatch DNA
repair proteins MSH2, MSH6 and MLH1, BLM and MRN complex are thought to form part of
BASC (BRCA1-associated genome surveillance complex), which has also been implicated as a
damage sensing complex (Wang et al. 2000).
The role of DNA-PK in sensing DNA damage is less clear than ATM and ATR. Some
studies suggested a role for DNA-PK in mediating checkpoint controls in response to DNA
DSBs (Woo et al. 1998), while others suggest a role in apoptosis (Wang et al. 2002). DNA-PK
signaling has also been shown to be important for NHEJ. During NHEJ, KU initially binds to
DNA ends followed by recruitment of DNA-PKcs, resulting in activation of its kinase activity
(Lees-Miller, Chen & Anderson 1990, Gottlieb, Jackson 1993). Cheong et al. demonstrated that
wortmannin mediated inhibition of DNA-PK activity affected the rejoining of DSBs in vivo, but
did not affect the process in vitro. This may suggest a purely regulatory/damage sensing role for
DNA-PK in intact cells rather than a direct end joining role. Following recognition of the
damaged DNA, a choice for repair pathway needs to be made. Over the years, there has been an
increasing interest in how the cells choose which DNA repair machinery to employ for repairing
the damage. Recent studies have focused on the molecular mechanisms that regulate this choice.
The repair pathway that is eventually employed may depend on several different factors that are
discussed in the following section.
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1.5 Choice of DNA DSB Repair Pathway
DNA DSBs can adversely affect cell viability and genomic stability. As discussed in the
previous section, cells have evolved groups of proteins that sense DSBs, arrest cell cycle and
activate DNA repair pathways. Eukaryotic cells repair DSBs primarily by two mechanisms:
NHEJ and HRR. The choice of repair pathway may depend on the cell type, cell cycle phase
(G1/G2/S), site of DNA DSB/accessibility by repair factors (Euchromatin vs heterochromatin)
and availability of homologous repair template.
It has been known for some time that a critical factor governing the balance between
NHEJ and HRR is the cell cycle phase. Cells have been shown to upregulate HRR during S and
G2 phases of the cell cycle because of the availability of a template. Sister chromatids are the
preferred template for HRR in mammalian cells. Cohesins (Proteins required for sister chromatid
cohesion) have been shown to migrate to DSB repair sites and mediate checkpoints (Lightfoot et
al. 2011). Though HRR is the favored mode of DNA repair in S/G2 phases, NHEJ remains active
throughout the cell cycle. This may suggest that NHEJ could compete for DSBs even when
homologous templates are in the vicinity of the break. Biochemical experiments suggested that
both NHEJ and HRR proteins bind to broken DNA ends, and plasmid DNA transfected into
mammalian cells could be repaired by either pathway. Therefore, the field moved into
investigating whether the initial repair factors that are recruited to DSBs could be regulating this
switch from NHEJ to HRR and vice versa.
Early studies have shown that RAD51 and RAD52 expression increases during S-phase
(Chen et al. 1997). Cyclin dependent kinase 1 (CDK1), which is a key regulator of cell cycle
progression also enhances Mre11 mediated DNA end resection leading to increase in the length
of 3ʹ single stranded DNA tails that may get bound by RPA and RAD51 to promote strand
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invasion for HRR (Ira et al. 2004). Moreover, phosphorylation of S2056 and T2609 clusters on
DNA-PK which is required for NHEJ is reduced in irradiated S-phase cells. All these processes
could be part of a regulatory mechanism that downregulates NHEJ and enhances HRR in S/G2
phases of cell cycle (Chen et al. 2005).
A defect in NHEJ could also lead to shunting of DSBs through the HRR pathway. Some
proteins like Mre11, BRCA1, H2AX, PARP1, DNAPK and ATM play roles in both pathways
(Roth, Wilson 1985, Allen et al. 2002, Pierce et al. 2001). Therefore, a possibility exists that one
or more of these proteins may be implicated in regulating preference of DNA repair pathway
employed to repair the damage.
PARP1 has also been directly implicated in repair pathway choice. It functions with
Ligase ΙΙΙ in an alternate low fidelity NHEJ pathway, where PARP1 competes with KU for DSB
ends (Wang et al. 2006). PARP1-defective cells were found to possess reduced HRR repair
(These cells showed camptothecin hypersensitivity) which was restored by inducing mutations
that inactivate NHEJ (Saberi et al. 2007). Defects in RAD18 showed similar defect and a double
PARP1/RAD18 mutant showed synergistic hypersensitivity to camptothecin, implicating both
proteins in promoting HRR and inhibiting NHEJ (Saberi et al. 2007). Recently, CtIP-BRCA1
complex was shown to modulate repair pathway choice. Phosphorylation of serine 327 of CtIP as
cells enter S phase and recruitment of BRCA1 may act to switch repair pathway from NHEJ to
HRR (Yun, Hiom 2009). Once the pathway choice is made mammalian cells repair DSBs by
either HRR or NHEJ.
1.6 Homologous Recombination Repair
Homologous recombination repair (HRR) represents a high fidelity pathway for repair of
DNA DSBs that depends on the availability of homologous sequences in the form of sister
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chromatids, homologous chromosomes or DNA repeats for sequence information to replace lost
nucleotides from the break site. Generally HRR is considered error free and is most active in the
S/G2 phases of the cell cycle (Takata et al. 1998).
HRR appears to involve a large group of proteins, including RAD51, RAD52, RAD54,
RAD55, RAD57, BRCA1, BRCA2, XRCC2, XRCC3 and MRN complex. The first event is
believed to be a 5ʹ3ʹ resection that leads to formation of ssDNA overhangs that are bound by
RPA (single stranded DNA binding protein), RAD51, RAD52 and RAD54. RAD51 forms
nucleoprotein complexes on ssDNA tails coated with RPA and may help in initiating strand
exchange while RAD52 forms ring structures consisting of seven RAD52 monomers that may
help RAD51 in forming DNA exchange intermediates. The RAD54 protein has ATPase activity
and mediates DNA unwinding (Baumann, West 1998, Dronkert et al. 2000). The RAD55 and
RAD57 exist as heterodimers and interact with RAD51 facilitating strand exchange. BRCA1 and
BRCA2 (Breast cancer susceptibility proteins) are also thought to be physically associated with
RAD51 at the DSB repair foci and are linked with DNA repair by virtue of their BRCT domain.
Embryonic stem cells deficient in BRCA1 show greatly reduced repair of chromosomal DNA
DSBs by HRR (Moynahan et al. 1999). BRCA2 binds to RAD51 through its carboxy terminus
and mediates delivery of RAD51 preferentially to ssDNA. Disruption of BRCA2 by targeted
truncation makes mouse cells susceptible to UV and MMS (Methyl methane sulfonate).
BRCA1-/- and BRCA2 -/- mouse fibroblasts develop chromosomal aberrations further
strengthening the role of these proteins in DNA repair. Following the early stages of HRR,
BRCA1 may also serve as an anchor to co-ordinate the repair events. MRN complex, along with
other nucleases (CtIP) may resect the DNA to generate ssDNA ends for DNA pairing and strand
exchange facilitated by RAD51 and RAD51 homologs/paralogs to form Holliday junctions. Now
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either the Holliday junctions disengage and DNA strands pair or a crossing-over event may result
in Holliday junction resolution, followed by gap filling. However, MRN complex has only been
shown to possess a 3ʹ5ʹ and not 5ʹ3ʹ exonuclease activity, hence other nucleases were
hypothesized to be involved in carrying out the required resection. CtIP is the recently
discovered nuclease that is suggested to play this role. Both C and N terminal of CtIP has been
shown to interact with the NBS1 subunit of MRN complex (Chen et al. 2008, Yuan, Chen 2009,
Sartori et al. 2007). CtIP is phosphorylated by ATM as well as CDK, and ubiquitinated by
BRCA1 leading to its recruitment to DNA ends. This recruitment is thought to commit the cell to
end resection and repair by HRR. CtIP along with MRN has been shown to be required for the 5ʹ
DNA end resection following which the ssDNA is bound by RPA and subsequent steps of HRR
can occur.
1.7 Non-homologous end joining
Non-homologous end joining (NHEJ) is regarded as the predominant DNA DSB repair
pathway in mammalian cells at least in G1/G0 phase of the cell cycle, though there is evidence
that it is active throughout the cell cycle. NHEJ does not require sequence information from an
intact copy on homologous chromosomes for repair, hence the term ‘non-homologous’ (Roth,
Porter & Wilson 1985). The most entrancing aspect of NHEJ is its ability to accept a diversity of
substrates and convert them to joined products. This demands a great deal of flexibility in
mechanical interaction of involved proteins to accept a plethora of different substrates that are
generally produced following exposure to ROS. Radiation and the resulting ROS can interact
with DNA to produce multiply damaged sites/complex DNA damage with different lengths of
overhangs, end termini blocked with 4ʹ-oxidation products and several types of base damage
most commonly 8-oxoguanine and thymidine glycols. These variously modified overhangs are
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joined in vivo by NHEJ regardless of the sequence, overhang length, DNA end sequence or DNA
end chemistry.

1.8 Mechanism of Non-homologous end joining
An oxidatively induced DNA DSB arising in mammalian cells often bears 3ʹ-staggered
termini with chemically modified ends. Ku heterodimers are thought to be the first proteins that
bind to DSBs and have a strong equilibrium dissociation constant (approx. 10-9 M) for duplex
DNA ends of varied conformations (Mimori, Hardin 1986). Ku then binds to DNA-PK and the
KU: DNA-PK complex can serve as a node where nucleases, polymerases and ligases can bind
(Lieber 2008). Ku can form stable complexes with DNA-PK only in the presence of DNA ends
(Yaneva, Kowalewski & Lieber 1997), likely because of a change in conformation when bound
to DNA. This change in conformation may also facilitate interaction of Ku with DNA
polymerases μ and λ along with XRCC4:DNA ligase IV complex (Nick McElhinny et al. 2000,
Chen et al. 2000). The Ku: DNA-PK holoenzyme may occupy approx. 30bp from the DNA end
(Walker, Corpina & Goldberg 2001, Leuther et al. 1999). Formation of the Ku: DNA-PK
holoenzyme also leads to the activation of its kinase activity. DNA-PK can then phosphorylate
various DNA repair proteins. Artemis in presence of DNA-PK gains a 3ʹ-endonucleolytic
activity that has been shown to resolve 3ʹ-PG-terminated DNA DSB ends and various secondary
structures in vitro. It is this endonucleolytic activity of Artemis that helps promote
radioresistance and DNA DSB repair proficiency in mammalian cells (Mohapatra et al. 2011).
Since Artemis: DNA-PK complex is able to endonucleolytically cleave a variety of damaged
DNA overhangs (Ma, Schwarz & Lieber 2005, Yannone et al. 2008), there is no obvious need
for other proteins with similar activities, however TDP1, APE1 and Metnase are some
possibilities.
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Figure 1-2. Nonhomologous end joining. The Ku 70/80 heterodimer forms a ring structure that
binds to DNA DSB ends and helps in the recruitment of DNA-PK. This is followed by the
recruitment of XLF:XRCC4:DNA ligase IV to the DNA ends which in turn leads to the synapsis
of the two ends. DNA-PK autophosphorylation causes a conformational change causing it to
move away from the DNA-termini, allowing Artemis and other endonucleases to process the
ends before gap filling by pol μ and λ and ligation mediated by DNA ligase IV. Adapted from
(Povirk, Valerie 2003)
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The apurinic endonuclease APE1 can remove 3ʹ-PGs from blunt and recessed 3ʹ ends, not
from protruding overhangs (Demple, Harrison 1994a, Haring et al. 1994, Suh, Wilson III &
Povirk 1997). TDP1 (Tyrosyl DNA phosphodiesterase 1) can remove glycolate residue from 3ʹ
ends, however additional processing by PNKP is required to remove 3ʹ phosphates left behind by
TDP1 (Inamdar et al. 2002, Jilani et al. 1999). However, PG removal by these enzymes may be
suppressed when the DNA ends are sequestered by repair complex and Artemis may be the only
enzyme that acts in the context of repair complex. Alternatively, these enzymes may work on
multiple redundant pathways to repair similar 3ʹ-PG terminated DSBs.
Various evidence support that a complex of XLF:XRCC4:DNA ligase IV helps in
alignment of partially cohesive ends for gap filling and ligation (Chen et al. 2000, Gu et al. 2007,
Lee et al. 2003). DNA Polymerases μ and λ can bind to the KU:DNA-PK complexes by their
BRCT domains located in the N-terminal portion of the polymerases (Ma et al. 2004) and unlike
replication polymerases, can carry out template-independent synthesis. It is also likely that DNAPK may relinquish its position at DNA ends following its autophosphorylation to allow the gap
filling enzyme complex KU:XRCC4:Ligase IV:Pol μ/λ, access to the extreme ends of DNA.
The various enzymes that take part in the NHEJ pathway have a great deal of mechanical
flexibility in their specificity of binding to DNA lesions, which in turn allows them to act on
wider range of starting DNA end structures.
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1.9 Structural and biochemical properties of various NHEJ proteins
Ku
Ku is a heterodimer consisting of a 70 kDa (Ku70) and a 86 kDa (Ku80) subunit based on
protein gel mobility assays (Walker, Corpina & Goldberg 2001, Valerie, Povirk 2003). It was
first identified as an autoantigenic protein from a scleroderma patient with initials K.U. The ring
shape of Ku is consistent with the property of Ku to bind DNA ends and its ability to slide
internally allowing other DNA repair proteins access to DNA ends (Mimori, Hardin 1986).
X-ray crystallography studies have shown that Ku occupies approx. 16 bp of double helical DNA
at DNA ends (Walker, Corpina & Goldberg 2001). The two subunits interact with each other
through their carboxy-terminal domains. A minimum of 28 amino acids in the center of Ku80 are
critical for Ku heterodimer complex formation (Wu, Lieber 1996). It also has more affinity for ds
DNA (dissociation constant of 1-2nM) than ssDNA (diss. const of 300nM) (Tuteja et al. 1994).
Neither subunit alone can bind to DNA efficiently suggesting that Ku70 and Ku80 functions are
interdependent. Ku has also been shown to form a bridge between DNA ends that may help in
aligning the two ends together for carrying out further steps of repair (Ramsden, Gellert 1998). It
recruits DNA-PK to DNA ends, which then occupies extreme ends of DNA displacing Ku
approx. 10 bp into the interior (Yoo, Dynan 1999). DNA-PK holoenzyme complex occupies
approx. 30 bp from the DNA end as suggested by DNase footprinting. In addition to DNA
alignment and facilitation of DNA-PK recruitment, recently Ku was identified as an effective
5ʹ-dRP/AP lyase and was found essential for the removal of AP sites near DSBs (Roberts et al.
2010). The end-joining of such breaks decreased in cells that were complemented with lyase
deficient Ku mutant.
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DNA-PK
DNA-PK belongs to the family of phosphatidylinositol-3 kinase (PI3K) and is a large
protein with a molecular weight of 469 kDa (Hartley et al. 1995). Its kinase activity is
specifically activated by binding to duplex DNA ends of various DNA end conformations (Smith,
Jackson 1999). The equilibrium dissociation constant for DNA-PK:Ku holoenzyme is tighter
than for DNA-PK alone towards blunt DNA ends (West, Yaneva & Lieber 1998), suggesting that
Ku facilitates DNA-PK binding to DNA ends. However, DNA-PK catalytic subunit can bind to
DNA in the absence of Ku and the binding was competitively inhibited by ssDNA or supercoiled
DNA (Hammarsten, Chu 1998, Hammarsten, DeFazio & Chu 2000). This suggests that DNA-PK
can be activated by its direct interaction with dsDNA and Ku was needed to stabilize DNA-PK
binding. Once bound, DNA-PK acquires S/T kinase activity (Hartley et al. 1995), and one of its
initial target is DNA-PK itself, with more than 15 autophosphorylation sites already identified
(Meek, Dang & Lees-Miller 2008). Two major autophosphorylation clusters termed ABCDE and
PQR have been extensively studied and span residues 2609-2647 and 2023-2056 respectively.
This autophosphorylation of the two end-bound DNA-PK molecules may lead to its dissociation
from DNA ends to allow further processing (Valerie, Povirk 2003, Karran 2000). Biochemical
experiments have shown that a minimum of 12 bp DNA was required to activate its kinase
domain (Leuther et al. 1999). Several studies indicated that overhangs were more robust
activators of the DNA-PK kinase activity than DNA ends with blunt DNA termini (Hammarsten,
DeFazio & Chu 2000, Smider et al. 1998, Jovanovic, Dynan 2006).
DNA-PK preferentially phosphorylates serine and threonine sites followed by a
glutamine (S-T/Q sites). There is a long list of proteins that possess DNA-PK target sites,
however the functional relevance of many of these phosphorylation events need to be studied
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further. Most of the known NHEJ factors XRCC4, KU 70/86, Artemis, DNA-PK and XLF are
excellent in vitro and in vivo targets of DNA-PK. DNA-PK-mediated autophosphorylation is
critical for Artemis endonucleolytic activity. Activated DNA-PK has also been shown to
stimulate the ligase activity of XRCC4:DNA ligase IV complex (Meek, Dang & Lees-Miller
2008)
Previous work from several investigators has defined three major domains in DNA-PKs
(Llorca, Pearl 2004, Boskovic et al. 2003, Rivera-Calzada et al. 2005). The N terminal repeat
regions comprise of palm domain that consists of the proximal and the distal claw. An arm
connects the N-terminal palm domain to the head domain consisting of the FAT, PI3K and the
FATC domain. Assembly of DNA-PK onto Ku-bound DNA induces a conformational change in
the protein such that the two globular domains come into contact to form a channel for DNA
ends to reside. The DNA-PK is thus essential for various stages of NHEJ, especially the
nucleolytic step and the ligation step.

Mre11/Rad50/Nbs1 (MRN complex)
Mre11, Rad50 and Nbs1 were first identified in yeast when screening for genes involved
in resistance to DNA damage and meiotic recombination. Ogawa and co-workers demonstrated
that Mre11, Rad50 and Xrs2 (The Saccharomyces cerevisae homolog of vertebrate-specific Nbs1)
belong to the same epistasis group and were further shown to associate with each other
physically (Johzuka, Ogawa 1995, Ogawa et al. 1995).
Mre11 is a conserved 70-90kDa protein composed of an N-terminal phosphoesterase
domain, and two distinct C-terminal DNA-binding domains (Williams, Williams & Tainer 2008,
Jackson 2002). The hMre11 gene is located on chromosome 11q21. The recombinant protein by
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itself resects DNA ends in 3ʹ-5ʹ direction in a manganese-dependent manner and the 3ʹ resection
activity increases 3-4 fold in conjunction with Rad50. This process was shown to be ATPindependent (Paull, Gellert 1998). Mre11 is more efficient with 3ʹ ends of a branched DNA than
with 3ʹ flaps or 3ʹ overhangs and promotes opening of DNA hairpin loops (Paull, Gellert 1998).
In vivo, Mre 11 dimer binds to a Rad50 dimer to form a core complex. The Nbs1 or Xrs2
proteins binds to this core complex via interactions with Mre11, however there is some
discrepancy over the number of Nbs1 proteins associated with the Mre11:Rad50 core (Lamarche,
Orazio & Weitzman 2010).
Nbs1 is a 65-85 kDa protein that consists of an FHA domain and two BRCT domains at
its N-terminus, in addition to an Mre11 interaction domain at its C-terminus (Lloyd et al. 2009,
Williams et al. 2009). These domains allow phospho-dependent interactions that are essential for
recruiting repair proteins to DNA breaks. Nbs1 is also responsible for translocation of MRN
complex into the nucleus and its mutants lacking the Mre11 binding domain are themselves
nuclear while Mre11-Rad50 dimer complex is cytoplasmic (Desai-Mehta, Cerosaletti &
Concannon 2001). Nbs1 stimulates the DNA binding and nuclease activities of the Mre11-Rad50
dimer complex. The central region of Nbs1 contains several SQ motifs that serve as
phosphorylation targets of ATM kinase as part of the DNA damage signaling process. The Cterminus also contains an ATM interaction domain that may function to recruit ATM kinase to
DNA DSB ends (Falck, Coates & Jackson 2005, You et al. 2005). Thus Nbs1 contributes to
DNA DSB repair by providing several protein-protein interaction motifs rather than a direct
enzymatic activity at DSB ends.
Rad50 is a 150 kDa protein that forms a homodimer and has a sequence and structural
homology to SMC (Structural Maintainance of Chromosome) family members. The N-terminal
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Walker A and C-terminal Walker B nucleotide binding moieties associate with each other to
form ABC-type ATPase domain (Hopfner et al. 2000) which has been implicated in DNA double
strand unwinding. Rad50 also contains of a 575-amino acid long coiled coil that spans approx.
500 Å and terminates with a CxxC motif that acts as a zinc hook. This zinc hook helps in
tethering the two ends of DNA DSB for repair. The zinc-mediated Rad50 dimer is extremely
flexible and can tether DNA ends about 1200 Å apart. This allows movement of tethered DNA
ends for homology directed repair (Hopfner et al. 2002).
MRN complex thus plays multiple roles in DNA DSB repair by both homologous
recombination and Non-homologous end joining pathways.

XLF/XRCC4/DNA-ligase IV
The XRCC4 gene was originally identified by complementation of radiosensitivity and
DSB repair deficiency of the CHO derivative XR-1 (Li et al. 1995). It consists of a globular head
and a long α-helical tail. Crystal structure of XRCC4 has revealed that four XRCC4 monomers
form a dumb-bell shaped homotetramer with two globular head and four tails that interact with
each other. Both XLF and DNA ligase IV are present in a complex with XRCC4. (Lee et al.
2000).
The crystal structure of XLF (Cernunnos) suggests a similarity to the structure of XRCC4,
with a globular head and a coiled-coil C-terminus, where multimerization occurs (Andres et al.
2007). Interaction between XRCC4 and XLF was identified through a yeast two hybrid system
that led to the discovery of XLF (Ahnesorg, Smith & Jackson 2006). Another study
demonstrated that residues 1-128 on XLF and residues 1-119 on XRCC4 are the minimal regions
required for their interaction, suggesting that both proteins interact with their head domains
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(Deshpande, Wilson 2007). In particular Leu115 located in the XLF β6-β7 loop is important for
the XLF-XRCC4 interaction (Andres et al. 2007). Deficiency of XLF in humans leads to
radiosensitivity with associated microcephaly (Buck et al. 2006) and a lack of V(D)J
recombination. XLF-deficient cells also fail to rejoin a substantial fraction of radiation induced
DSBs. In vitro reactions with purified proteins have shown XLF to stimulate ligation by X4L4.
Our lab has shown that alignment-based gap filling is completely dependent on XLF in whole
cell extracts suggesting that Cernunnos not only stimulates ligation by ligase IV, but may also be
important for DNA alignment (Akopiants et al. 2009). Another possibility for XLF dependence
for gap filling could be a requirement for proper positioning of pol λ or pol μ. However,
experiments have shown that Ku and X4L4 alone are sufficient to recruit polymerases to DNA
ends. Mutation of two phosphorylation sites S245A (DNA-PK dependent) and S251A (ATM
dependent) did not alter either repair efficiency or repair fidelity of XLF. A DNA-PK inhibitor
(KU57788) inhibited end joining mediated by XLF suggesting that presence of XLF and
catalytically active DNA-PK is required for end joining while ATM inhibitor KU55933 had no
effect on XLF-mediated end joining reaction (Akopiants et al. 2009).
DNA ligase IV was initially co-purified with DNA ligase III in Hela nuclear extracts and
was later shown to co-immunoprecipitate with XRCC4 (Grawunder et al. 1997). DNA ligase IV
binds to XRCC4 at a site close to middle of the α-helical tail (Sibanda et al. 2001). Furthermore,
it exists as a tight hetero-tetrameric complex with XRCC4 and is not detectable in cells lacking it
(Lee et al. 2000, Bryans, Valenzano & Stamato 1999). DNA ligase IV consists of N-terminal
core catalytic domain and a carboxy-terminal domain with two tandem copies of BRCT
(Callebaut,I. 2006) and it is through the BRCT domains that ligase IV interacts with XRCC4
(Critchlow,S.E. 1997). Contacts between KU and ligase IV, and between DNA-PKcs and

20

XRCC4 mediate binding of XRCC4/ligase IV to DNA-PK at the DNA end termini (Valerie,
Povirk 2003, Hsu, Yannone & Chen 2001). DNA-PKcs phosphorylates XRCC4 on serine and
threonine residues in the carboxy terminal of the protein (Leber et al. 1998), however, the
relevance of this phosphorylation to NHEJ is still not clear. Analysis of the effect of DNA-PKcs
on ligation by XRCC4/ligase IV complex showed that both proteins bind to the same DNA
molecule and that such binding promotes intermolecular ligation as opposed to intramolecular
ligation seen with XRCC4/ligase IV complex alone (Chen et al. 2000). These studies suggested
that XLF/XRCC4/ligase IV may serve as an alignment factor to bind DNA ends together
allowing for ligation to proceed following repair by NHEJ.

Promyelocytic leukemia protein
PML nuclear bodies are very interesting sub-nuclear compartments of 0.1 μm-1 μm in
diameter due to their prominence in the nucleus. The main constituent of PML NBs is the PML
protein itself, which is a known tumor suppressor and a key organizer of these domains. PML
protein helps recruit other factors to these domains like SP100, Daxx and CBP etc, whose only
known common feature is their ability to be sumoylated (Lallemand-Breitenbach, de Thé 2010,
Yang et al. 2002, Bernardi, Pandolfi 2007). These bodies vary from generally 5-15 per nucleus
and do not contain RNA or DNA (Boisvert, Hendzel & Bazett-Jones 2000). Although devoid of
DNA, PML nuclear bodies may be associated with some specific chromosomal loci where they
are proposed to modulate transcription and chromatin architecture (MHC gene cluster 1)
(Lallemand-Breitenbach, de Thé 2010).
PML is phosphorylated by several DNA damage-activated kinases like ATM, ATR and
Chk2 and has itself been proposed to act as DNA damage sensor (Dellaire et al. 2006). PML-
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NBs have also been implicated in DNA repair due to recruitment and release of several DNA
sensing/repair factors like BLM helicase, Mre11, WRN, p53 and TOPBP1 in a DNA damage
dependent manner (Dellaire, Bazett-Jones 2004, Carbone et al. 2002, Bischof et al. 2001).
Though PML-NBs partially overlap with unrepaired γ-H2AX foci, their localization to
actual DNA damage sites need to be further investigated and is currently disputed (Mohapatra et
al. 2011, Lallemand-Breitenbach, de Thé 2010, Boe et al. 2006). PML-/- cells and mice have
been shown to more resistant to lethal effects of γ-radiation than PML+/+ cells. Cds1/Chk1
mediated phosphorylation of PML mediates apoptosis (Yang et al. 2002), probably through
recruitment of Daxx to NBs (Zhong et al. 2000). Our results that PML NBs partially juxtapose
with
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fact that these foci regulate many aspects of DNA DSB repair.
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INTRODUCTION TO THESIS

2.1 Nuclease processing of blocked DNA end termini
During NHEJ, the damaged DNA end termini are recognized, bound, aligned and stabilized
by Ku/DNA-PK complex, followed by processing of DNA to create ligatable ends. Most DNA
DSBs resulting from exposure to ionizing radiation and radiomimetic chemotherapeutics bear
chemically modified end termini that must be removed before patching and re-ligation can
follow. The most commonly found blocked terminus following free radical-induced DSBs are
3ʹ-phosphates and 3ʹ-phosphoglycolates (Henner et al. 1983) while some ends may bear a
5ʹ-aldehyde (Dedon, Goldberg 1992, Povirk 1996). It has also been shown that such blocked
DNA ends may also have accompanying base damage, especially following radiation exposure
(Nikjoo et al. 1997, Zhou et al. 2008). Such multiply damaged sites are the most difficult to
repair and are major determinants of survival following radiation exposure or therapeutic
radiation treatment. The NHEJ machinery has evolved many endonucleases to resect such
modified termini, and to resolve blocked 3ʹ-phosphoglycolate ends, Artemis, TDP1 and APE1
have been implicated. However, their role in resolving complex DNA damage is still under
investigation. This thesis investigates the role of Artemis and newly discovered Metnase
endonucleolytic function for resolving such damage and promoting DSB repair.
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2.2 Artemis
Artemis was named after the Hellenic goddess of the hunt who aids in childbirth and is
considered a protector of children. It was identified as a 77.6 kDa protein (685 amino acids)
coded from the short arm of chromosome 10, responsible for radiosensitive-severe combined
immunodeficiency (RS-SCID) or Athabascan SCID (SCIDA) (Moshous et al. 2001). Autosomal
recessive mutation of this gene is lethal within the first year of life due to occurrences of severe
opportunistic infections. Several in vitro and in vivo studies have revealed that Artemis nuclease
is required for the resolution of hairpin coding ends during V(D)J recombination (Li et al. 2005,
Ma et al. 2002), a critical point in the development of immune system. Defect in Artemis leads to
a T- B- NK+ phenotype, due to an arrest of the B and T cell maturation at early stages. Artemisdeficient cells also display increased sensitivity to radiation and radiomimetics suggesting that it
is also required for DSB repair by NHEJ.

Structural properties of Artemis
Artemis belongs to SNM1 family of proteins and is homologous to yeast SNM1 gene
products. Since the crystal structure of Artemis has not been determined yet, most of the
structural properties of the protein have been derived from biochemical analysis over the past
decade. The N-terminal region of the protein has a metallo-β-lactamase domain spanning amino
acids 1-155 and a β-CASP (metallo-β-lactamases-associated CPSF ARTEMIS SNM1 PSO 2)
domain spanning 156-385 amino acids (Callebaut et al. 2002). The β-CASP domain is highly
conserved among metallo-β-lactamases acting on nucleic acids. Pannicke et al selected four
conserved aspartic acid residues (D17, 37, 136, 165) and five histidine residues (H33, 35, 38,
115, 319) in the conserved metallo-β-lactamase/ β-CASP domain of Artemis for further analysis.
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These aspartic acid and histidine residues are present in the Artemis active site and are thought to
co-ordinate metal ions for a nucleolytic attack onto the DNA (Pannicke et al. 2004). Experiments
with Artemis mutated for the above residues revealed that D37 and histidines 33, 35, 38, 115 and
319 directly co-ordinate metal ions. Thus mutation in these residues reduces or abolishes binding
of both metal ions and nucleolytic function. Aspartic acid residues 17, 136 and 165 do not
directly bind to metals but may form salt bridges to the HxHxDH motif backbone and the side
chain of H38 and 33 to probably stabilize the conformation of the HxHxDH motif for coordination of the metal ions. The D165 residue is interesting and unique because it is not
available in the crystal structure of available metallo-β-lactamases, however it is important to
Artemis endonuclease activity since a mutation in this residue completely abrogates Artemismediated endonucleolytic cleavage (Yannone et al. 2008, Pannicke et al. 2004). The D165
residue may thus be present in the active site of Artemis to help co-ordination of the metal ions.
More recently, another histidine residue H254 in the β-CASP domain has been shown to be
important for the full in vitro and in vivo functions of the protein. A H254A mutant Artemis was
endonucleolytically inactive and failed to complement the V(D)J recombination defect of
GUETEL cells (SV40 transformed, htert immortalized skin fibrobalsts from a RS-SCID patient)
(de Villartay et al. 2009). However, the 5ʹ-exonuclease activity remained unaffected. The H254
is functionally important because of its location in the β-CASP region outside of the metallo-βlactamase domain (All other amino acids important for endonuclease activity of Artemis are
located in the metallo-β-lactamase domain). Moreover, H254 is located in the most variable
region of metallo-β-lactamase family of proteins, yet is conserved in Artemis. It is speculated to
co-ordinate zinc ions in the active site of Artemis, but its exact role at the molecular level needs
to be further characterized.
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Biochemical properties of Artemis
Artemis has been shown to possess ssDNA specific 5ʹ3ʹ exonuclease activity and it
acquires a 3ʹ5ʹ endonuclease activity when associated with DNA-PK (Yannone et al. 2008, Ma
et al. 2002). Dr. Lieber’s group synthesized and tested a hairpin substrate for Artemis function.
They observed the expected exonuclease activity of Artemis at the non-hairpin end of the hairpin
substrate but no hairpin opening activity of Artemis alone or with addition of Ku was detected.
However, in presence of DNA-PK the spectrum of Artemis activity shifted more towards the
endonuclease function (Ma et al. 2002). When longer internally labeled substrates were treated
with DNA-PK and Artemis, short 3ʹ overhangs (4-5 bases) were efficiently trimmed to 2-3 bases.
Duplexes with blunt ends or very short overhangs (1-2 bases) were trimmed more slowly than
longer overhang bearing substrates (Yannone et al. 2008). The trimming of blunt ends by
Artemis/DNA-PK is executed as trimming of the 5ʹ terminal (removal of approx. 6 bases) to
generate 3ʹ-overhangs that is then endonucleolytically cleaved as dinucleotides. However, in the
absence of DNA-PK, an extensive 5ʹ3ʹ resection dependent on the presence of a 5ʹ-phosphate
was detected. DNA-PK strongly suppresses the exonuclease and upon phosphorylation promotes
endonucleolytic trimming. This endonucleolytic activity has been shown to remove chemically
modified 3ʹ and 5ʹ-termini such as 3ʹ-PG and 5ʹ-aldehyde.
Blocking PG moieties on long 3ʹ overhangs did not influence Artemis endonuclease
activity; however, 3ʹ-PG moiety on shorter overhangs (closer to the cleavage site) altered
Artemis nuclease specificity. In reactions with plasmid substrates bearing a 3-base 3ʹ-PG
overhang, Artemis-mediated single-nucleotide removal was predominant. Moreover, the total
cleavage for the 3ʹ-PG-terminated end was higher than an analogous 3ʹ-phosphotyrosyl end and a

26

3ʹ-hydroxyl end which was left almost intact (Povirk et al. 2007). Based on the work performed
in our lab, Artemis-mediated cleavage of 3ʹ-overhangs was found to depend upon, requirement
for 2 nucleotides (or a nucleotide and a 3ʹ-PG) 3ʹ to the cleavage site or at least 2 unpaired
nucleotides 5ʹ-to the cleavage site and showed a preference for trimming of 4-5 bases on the
3ʹ-overhangs from the single/double strand border. There was a pronounced decrease in Artemismediated trimming for PG substrates having less than 3-base overhangs. For substrates having
3ʹ overhangs of less than 3 bases (blunt ends and 2-base overhangs), a 30 min Artemis treatment
yielded multiple cleavage products totaling less than 10 % of the initial substrate (Povirk et al.
2007).
The biochemical data taken together suggest a role for Artemis in resolution of
oxidatively damaged 3ʹ-PG terminated blocked DNA ends on long 3ʹ overhangs. 3ʹ-PG ends on
blunt and very short overhangs are also processed, but slowly. Artemis may also lack the
specificity to remove only the 3ʹ-PG lesions, since it excises a few terminal nucleotides, in turn
resolving the blocked end. This endonuclease activity of Artemis is stimulated by DNA-PK and
Ku, two NHEJ proteins. However, the role of Artemis in resolving multiply damaged
sites/complex DNA lesions with oxidative base damage needs to be biochemically studied and
has been addressed as part of this thesis.

Regulation of Artemis activity
Recent publications have tried to address how Artemis activity might be regulated.
Artemis has been shown to interact with phosphatidylinosytol-3 kinases like DNA-PK and ATM,
and is basally phosphorylated at S516 and S645 in cultured cells (Ma et al. 2002, Wang et al.
2005, Zhang et al. 2004, Riballo et al. 2004). ATR mediates hyperphosphorylation of Artemis
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after UV irradiation (Zhang et al. 2004). Following treatment with radiation or bleomycin,
phosphorylation of Artemis by ATM increases 10-15 fold at above mentioned positions. Coimmunoprecipitation studies showed an ATM-dependent interaction of endogenous Artemis with
Nbs1 (Chen et al. 2005) and the amount of Nbs1 interacting with Artemis increased following
irradiation. In vitro, ATM-mediated phosphorylation of Artemis at S645 was shown to be
dependent on the presence of MRN complex (Goodarzi et al. 2006). Nbs1 can form IRIF and
recruit ATM to sites of DSB (Falck, Coates & Jackson 2005), suggesting that Nbs1 may be
involved in recruitment and facilitation of ATM-mediated phosphorylation of Artemis at DSB
ends. This hypothesis is confounded by the fact that Artemis hyperphosphorylation by ATM is
dispensable for its endonuclease activity and for DSB repair/V(D)J recombination (Goodarzi et
al. 2006).
However, in ATM null cells, Artemis can also be phosphorylated redundantly by DNAPK (Chen et al. 2005, Goodarzi et al. 2006). Radiation treatment was found to enhance the
interaction between DNA-PKcs and Artemis (Zhang et al. 2004). Though the same group
observed a decrease in total Artemis levels on DNA-PK knockdown in cells, DNA-PK- deficient
MO59J cells do not show any decrease in Artemis levels (Drouet et al. 2006). Treatment of cells
with a DNA-PK inhibitor NU7026 abrogated the hyper-phosphorylation and cellular retention of
Artemis following DNA damage. The DNA-PK kinase activity stabilized the interaction of
Artemis with DNA-PK and DNA ends in presence of KU. Autophosphorylation of DNA-PK at
T2609-2647 in the presence of KU and DNA promotes Artemis endonuclease activity, possibly
by causing a conformational change in DNA-PK allowing Artemis access to DNA ends
(Goodarzi et al. 2006). An alternate hypothesis is that activated DNA-PK could optimally
organize DNA ends for endonucleolytic resection by Artemis.
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Artemis, a multifunctional phosphoprotein
Over the past few years there has been some progress in defining the various C-terminal
phosphorylation sites on Artemis but the role of this phosphorylation still remains unclear.
Current findings suggest that phosphorylation by PI3Ks do not regulate Artemis function in
NHEJ or V(D)J recombination, as a construct containing the Artemis catalytic core is fully
capable of restoring defects in these pathways due to Artemis deficiency (Poinsignon et al. 2004a,
Poinsignon et al. 2004b). Thus other groups have indicated a cell cycle regulatory role for
Artemis. Analysis of Artemis phosphorylation has revealed that the S534 and S538 sites are
rapidly phosphorylated and also dephosphorylated within 1 hour following IR treatment, while a
prolonged phosphorylation was observed at S516 and S645 (~24 hrs). These results may indicate
that phosphorylations at different regions of the protein may regulate separate functions. Studies
from Dr. Legerski’s laboratory have demonstrated that a S516A and S645A double mutant was
defective in recovery from G2/M cell cycle checkpoint (Zhang et al. 2004). They knocked down
Artemis in HEK 293 cells using a siRNA and irradiated these cells with 10 Gy γ-radiation.
Following irradiation, control siRNA treated cells remained arrested at the G2/M checkpoint
whereas Artemis-depleted cells did not. However, Artemis-mediated checkpoint arrest did not
seem to involve well established G2/M checkpoint arrest pathways that are known to function
downstream of ATM and ATR following DNA damage. Artemis is not required for damage
induced phosphorylation of Chk1, Chk2 or γ-H2AX. Moreover, its phosphorylation was also not
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Figure 2-1. Model of Artemis as a multifunctional phosphoprotein. Most of the
DSBs induced by either radiation or bleomycin are repaired by the classical NHEJ
pathway; however subsets of DSBs (10-20%) require Artemis nuclease for resolution
and subsequent repair. Artemis has also been shown to have cell cycle checkpoint
effects.
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inhibited by the Chk1 inhibitor UCN-01 suggesting that Artemis does not act downstream of
Chk1. Mutation of S516 and S645 residues to alanine resulted in defective recovery from the
checkpoint, while there was no effect of this mutation on DSB repair (Zhang et al. 2004). The
mutant

Artemis was further shown to promote an enhanced interaction between

unphosphorylated cyclin B and CDK1, which in turn promoted inhibitory phosphorylation of
CDK1 by the Wee1 kinase. The mutant Artemis also promoted centrosomal retention of cyclin B
and prevented its subsequent export to the nucleus (Geng et al. 2007). The model thus proposed
that ATM may regulate recovery from G2/M checkpoint by an early inhibitory phosphorylation
of Artemis, which may act as a molecular switch to allow cells to recover from checkpoint arrest
following DNA repair. In a separate work done by the same group, the authors showed that S516
and S645 was also phosphorylated by ATR in response to UV damage or replication stress
induced by aphidocolin (Wang et al. 2009). HEK 293 cells expressing S516A/S645A mutant
Artemis showed significant accumulation of cells in the S-phase of cell cycle 12-18 hrs
following UV exposure when compared to WT protein expressing cells. In addition,
S516D/S645D mutant Artemis-expressing cells (phosphorylation competent at these residues),
resulted in no S-phase checkpoint deficiency. Upon further analysis they found that CDK2
kinase (principal kinase regulating progression through S-phase), has reduced activity in cells
expressing S516A/S645A mutant. Moreover, cyclin E levels in these cells were significantly
higher in these cells following UV irradiation or aphidocolin treatment, whereas there were no
measurable differences in the cyclin A levels (Wang et al. 2009). Overexpression of cyclin E
could compete with cyclin A to bind to CDK2 thus affecting S phase cell cycle progression.
Artemis was also observed to interact with the F-box protein Fbw7, and this interaction may
regulate cyclin E degradation through the SCFFbw7 E3 ubiquitin ligase complex. Phosphorylation
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at S516 and S645 was shown to regulate interaction between Artemis and Fbw7. Artemis has
been shown to interact directly with DDB2 (Damaged DNA binding protein 2) and is a
component of the Cul4A-DDB1 E3 ligase complex. Several studies have implicated Cul4A
based E3 ubiquitin ligase complex in the ubiquitination and degradation of p27, an inhibitor of
CDKs and a cell cycle regulator. Artemis interacts with p27 and both Artemis and DDB2 may be
required for the ubiquitination and degradation of p27 mediated by the Cul4A-DDB1 complex
(Yan, Zhang & Legerski 2011). These findings taken together define a new role for Artemis as a
cell cycle regulator in proliferating tumor cell lines.
In addition to its cell cycle regulatory function, Artemis has been implicated in telomere
maintenance. Mouse cells defective in Artemis had increased frequencies of end to end
chromosome fusions and primary human fibroblasts derived from an RS-SCID patient showed
accelerated shortening of telomeres, suggesting a role for Artemis in maintaining telomeres
(Cabuy et al. 2005, Rooney et al. 2003). Analysis of Artemis defective cell lines by immunoFISH, using telomeric PNA and γ-H2AX antibody revealed that for older cell lines (PD values
32/33), Artemis-defective cells showed higher frequencies of spontaneous and radiation induced
(1Gy/24hr repair) γ-H2AX foci and TIFs (Telomeric dysfunction induced foci) than normal
“older” cell lines. DNA-PK knockdown (45%) also had greater effect (elevated levels of TIFs)
on telomeres in Artemis-defective cell lines than normal cells (Yasaei, Slijepcevic 2010). Since
Artemis has been speculated to help repair DNA DSBs in heterochromatic regions of DSBs and
telomeres are typical heterochromatic parts of the genome, it could be hypothesized that Artemis
may be required for repairing DNA damage originating in the telomeric regions of the genome.
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Artemis depletion in both tumor cell lines and primary fibroblast cells led to upregulation
and activation of p53 leading to activation of p21. In addition to cell cycle arrest, Artemis
depletion also led to upregulation of pro-apoptotic gene Bax in U2OS and Hela cells. It coimmunoprecipitated with p53 suggesting that both these proteins may exist as part of the same
complex in vivo. Artemis is also regulated by DNA-PK, ATM and ATR. Knockdown of
DNA-PK in Artemis-depleted cells affected p53 stabilization while a similar knockdown of
ATM did not (Zhang et al. 2009). These and other findings suggest that Artemis depletion results
in spontaneous phosphorylation and stabilization of p53 in a DNA-PK dependent manner
without requirement of DNA ends or KU heterodimers. Thus Artemis may also act as an
oncogene in the sense that an overexpression of Artemis may suppress p53 activity, thereby
promoting tumorigenesis. However the role of Artemis in apoptosis is not limited to regulation
of p53 activity and it was also reported to recruit onto damaged chromatin during apoptotic DNA
fragmentation (Britton et al. 2009). When human fibroblast cells were treated with either
calicheamicin (DNA DSB causing agent) or staurosporine, Artemis bound to apoptotic
chromatin along with DNA-PK in a time and drug dose dependent manner. Artemis-deficient
GUETEL cells showed a delay in DNA laddering compared to Artemis-proficient counterparts
possibly due to a defect in high molecular weight DNA fragmentation step of apoptotic
chromatin cleavage (A hallmark of apoptosis is that DNA fragmentation occurs as high
molecular weight fragments, followed by extensive internucleosomal cleavage). More recently it
was suggested that Artemis may be involved in endonucleolytic cleavage at internucleosomal
sites near an HO-endonuclease cut site releasing a ladder of 200 bp fragments (Kanikarla-Marie,
Ronald & De Benedetti 2011). This activity of Artemis was found to be enhanced by
wortmannin treatment (PI3K inhibitor), which otherwise should have inhibited instead of
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enhanced Artemis endonucleolytic function (due to inhibition of DNA-PK). However, this work
still suggests that Artemis endonucleolytic function may cleave DNA at the internucleosomal
sites to resolve blocked DNA ends.

Causative Artemis mutations in SCID patients
Athabascan SCID (SCIDA) or RS-SCID is a autosomal recessive inherited disease (gene
- -

+

frequency 2.1%) that is very rare in the general population, however the T B NK

immunophenotype has a very high incidence in (1:2000 live births) in Navajo and Apache Native
Americans believed to have originated from Athabascan speaking linguistic group. The SCIDA
condition is characterized by early onset of severe opportunistic infections and severe oral and
genital ulcers. Affected children generally die from these infections within six months without
bone marrow transplant.
Of the reported DCLRE1C (Artemis) alleles (96) in various families (43) reported in one
study, the most frequent mutations found were gross deletions (43.8%), while small deletions
(13.5%), small insertions(1%), missense point mutations (19%), nonsense point mutations (8%)
and point mutations of splice sites (12%) were also identified (Pannicke et al. 2010). In another
study where 58 mutated DCLRE1C alleles were described, the most frequent mutation was again
gross deletions (65%). The frequent exons that are deleted are exons 1-3 or exons 1-4 which are
N-terminal exons, while in few cases exons more towards C-terminal (exons 7-8, 10-12) were
also deleted (Pannicke et al. 2010). Most of the Artemis mutants described so far are functionally
null mutants. Small deletions in exon 14 allow residual hairpin cleavage activity in vivo. The
C-terminal domain contains residues that are phosphorylated by DNA-PK, and is thought to
regulate Artemis endonucleolytic function. These mutants thus have reduced activity even
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though they possess intact N-terminal endonuclease domain. However, truncation of C-terminal
residues may also lead to protein variants that are either not expressed or are not stable. A
hypomorphic mutation (AUG to ACG) in the start codon of DCLRE1C gene, was shown to
cause omen syndrome, possibly due to inefficient translation (Mancebo et al. 2011). Two hotspot
regions of missense point mutations that completely eliminate Artemis functions are in exons 1-2
and exons 5-6, that hold residues essential for Artemis endonucleolytic cleavage. However, a
genomic exon 3 deletion and a 2-nucleotide insertion in exon 14 resulting in frameshift and early
termination was also identified in four Japanese patients (Most of the SCID patients identified
earlier were Europeans or Athabascan speaking Native Americans) (Kobayashi et al. 2003). Thus
most mutations identified in Artemis gene are complex or nonsense mutation.

2.3 Metnase
Metnase (SETMAR) was identified as a SET and transposase fusion protein that was
shown to promote in vivo end joining activity and mediate foreign DNA integration. It contains
two functional domains: a SET [Su(var)3-9, Enhancer-of-zeste, Trithorax] domain that is
associated with histone methyltransferase activity at lysine 3, 4 and 36, and a DDE motif that is
essential for its DNA cleavage action (Lee et al. 2005b, Roman et al. 2007). Since its initial
discovery in 2005, Metnase has been implicated in influencing lentiviral integration, mediating
chromosome decatenation, promoting restart and repair of stalled and collapsed replication forks
and in repair of DNA DSBs by NHEJ.
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Structure and biochemical properties of Metnase
The crystal structure of Metnase predicted it to contain at least one helix-turn-helix motif
and a catalytic domain. The catalytic domain of Metnase transposase appears to form a dimer. In
all the crystal lattices obtained, there were two transposase domains that formed a dimer within
the asymmetric unit of the crystal, as characterized by gel filtration chromatography (Goodwin et
al. 2010). The dimerization of Metnase seemed to be required for the TIR sequence binding
activity and its DNA cleavage function. A F460 residue was proposed to be important for
dimerization, and an F460K mutant showed reduced TIR (terminal inverted repeat) binding and
DNA cleavage.
The Metnase gene extends over 13.8 kb located at 3p26 and has three exons. Two of the
exons form SET, pre-SET and post-SET domains while the third exon codes for the Mariner
transposase sequence that includes an HTF motif which mediates TIR binding. Metnase catalytic
domain has a DDN motif instead of the DDD/E motif commonly found in transposases
(Goodwin et al. 2010, Lee et al. 2005a). The SET domain is most related to SuvHar91 histone
methyl transferase, with 36% homology.

Metnase promotes foreign DNA integration
Metnase encodes a transposase domain similar to catalytic domains of retroviral
integrases and hence was postulated to promote viral DNA integration. Metnase enhanced
Moloney Leukemia virus DNA integration by fourfold and plasmid DNA integration by sixfold,
while Metnase knockdown reduced both viral and plasmid DNA integration (Lee et al. 2005a).
Further along these lines, overexpression of Metnase influenced genomic integration of intact
HIV cDNA from HIV infection of human cells, whereas reducing the levels
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Figure 2-2. Metnase mediated DNA end processing following radiation exposure. Exons 1
and 2 encode for the various SET domains and exon 3 codes for the transposase domain. The
nuclease activity of Metnase resides in the transposase domain (DDE like motif). Metnase
interacts with Pso4 and this interaction may be required for Metnase localization onto DSB ends
following DNA damage. Metnase has also been shown to interact with DNA ligase IV which
catalyzes the final ligation step in NHEJ. Though Metnase may form a part of the repair complex
on DNA ends it is still unclear whether its histone methylase activity or its end processing
function is important for DSB repair. (Adapted from Shaheen et al, 2010)
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of Metnase decreased the amount of HIV cDNA copies integrated into human genome
(Williamson et al. 2008a). However, it had no effect on total cellular viral RNA, cDNA or
double-LTR circles after infection. Thus, Metnase may be a target for treatment of HIV infection.

Histone methylase activity of Metnase
Metnase possesses a SET domain and hence was tested for histone methylase activity
using a SAM donor. Metnase transferred a radiolabelled [3H]-methyl group from SAM to
recombinant histone H3 as determined by autoradiography. Further analysis by Western blotting
revealed that Metnase stimulated specific dimethylation of histone H3 at lysine 36 (H3K36) and
lysine 4 (H3K4) in a concentration-dependent manner. However, this histone methylation
activity of Metnase was lesser at H3K4 than at H3K36 (Lee et al. 2005a). Western analysis also
revealed lesser Metnase mediated methylation of Histone H3 at K9, K27 and K79 or H4K20 and
H4K79. This Histone methylation function of Metnase may play a major role in regulation of
transcription, replication, DNA integration and DNA repair due to its chromatin modifying effect.

DNA cleavage function of Metnase
Since Metnase was a SET-transposase fusion protein with putative roles in DNA repair,
and had a DDE like motif, its nuclease activity was further investigated. Metnase was found to
possess a single strand nicking and a double strand endonuclease activity that converted a
supercoiled plasmid into nicked and linearized form. Since Metnase possesses a TIR-specific
DNA binding activity it was speculated that it may have a sequence-specific DNA cleavage
activity, however direct sequencing of cleavage products revealed that the cleavage occurred at
no defined sequence (Roman et al. 2007). The HTH motif that was essential for its TIR binding
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activity was not essential for its DNA cleavage activity, while the transposase domain was found
to be critical for this function. A D483 residue within the DDE-like motif within the transposase
domain is essential for DNA cleavage activity. A D483A mutant showed little or undetectable
DNA cleavage function even with substrate (DNA) incubations at higher protein concentrations
(Roman et al. 2007). These results suggest that DDE like motif within the transposase domain is
critical for the DNA cleavage activity of Metnase.
More recently Metnase’s endonuclease activity has been more carefully characterized
using DNA substrates mimicking endogenous DNA DSBs. It was found that Metnase
preferentially cleaves 50 mer ssDNA more readily than a blunt ended dsDNA with the same
sequence. To find a more physiological relevance to Metnase ssDNA cleavage function, its
activity towards a partial duplex substrate was examined. It showed preferential cleavage of the
ssDNA region of a 5ʹ-overhang and a 3ʹ overhang was cleaved at both single stranded and double
stranded regions (Beck et al. 2011). This ssDNA cleavage activity of Metnase was also
preferentially directed towards partial DNA duplexes with flaps and pseudo Y structures. When
the protein was incubated with hairpin DNA or loop DNA, it did not show endonucleolytic
activity at the ssDNA region (Beck et al. 2011). It was also found that this endonuclease function
of Metnase is essential for promoting NHEJ in cell extracts (Beck et al. 2011, Shaheen et al.
2010). A linearized pBS DNA was incubated with cell extracts containing increasing amounts of
the protein and the circular duplex DNA generated from end joining was transformed into E.coli
for colony formation on ampicillin resistant plates. Cell free extracts obtained from Metnaseoverexpressing HEK 293 cells stimulated end joining, when compared to Metnase-depleted cell
extracts. Addition of purified wt Metnase restored end joining activity while addition of D483A
mutant did not stimulate end joining. End joining in Metnase-containing extracts required ATP
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and Mg2+ and was inhibited by wortmannin (PI3K inhibitor) (Beck et al. 2011), also affecting
E.coli colony formation following transformation. These data suggest a role for Metnase in end
joining following DNA damage.

Metnase in chromosomal decatenation and replication fork restart
DNA replication results in intertwined sister chromatids that must be decatenated to
ensure proper segregation and to prevent chromatid breaks during anaphase. Metnase has been
shown to interact with TopoIIα, the principal decatenating enzyme, which works by creating
transient DNA DSB (Williamson et al. 2008c). Nuclear extracts containing Metnase promoted
TopoIIα mediated decatenation of highly interlocked DNA to relaxed circular forms more
rapidly than those lacking Metnase. Overexpression of Metnase was found to promote
progression through metaphase decatenation checkpoint and survival after exposure to VP16, a
TopoIIα inhibitor (Wray et al. 2009a, Williamson et al. 2008b). Knocking down Metnase
significantly sensitized breast cancer cells to Adriamycin and AML cells to etoposide (Wray et al.
2009b). Thus Metnase could be used as a target to increase sensitivity of TopoIIα inhibitors.
Metnase also promotes resistance to agents that cause replication stress by enhancing
restart of stalled or collapsed replication forks. Metnase knockdown greatly enhanced sensitivity
of cells to UV rays and camptothecin due to a marked defect in restart of stalled replication forks
(De Haro et al. 2010). Log-phase HEK 293 cells were stably transfected with shRNA targeting
Metnase and a control RNA, incubated with IdU and treated with hydroxyurea (HU), then
incubated with CldU. IdU was labeled red and CldU green and stretched DNA fibers were
quantified by confocal microscopy. Adjacent red-green signals showed continuing replication
forks, while gaps indicated stalled forks. There was a marked decrease in the number of stopped
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and continuing replication forks in Metnase depleted cells following treatment with HU (De
Haro et al. 2010). Metnase was also shown to interact with PCNA, RAD9 and 9-1-1 complex
that have roles in intra-S-phase checkpoint and restart of stalled replication forks. Together these
results establish that Metnase may play a key role in cell survival following exposure to agents
causing replication stress by promoting restart of stalled forks.

Metnase in DNA repair
Given its histone methylating and DNA cleavage function, the role of Metnase in DNA
repair was postulated. Overexpression of Metnase did not alter repair of DNA DSB by HRR, but
it was found to enhance NHEJ. Conversely, Metnase knockdown reduced NHEJ by 12-20 fold,
while mutations in essential residues within SET or transposase domains ablated
NHEJ-enhancing Metnase activity (Lee et al. 2005a). It was found to co-immunoprecipitate with
NHEJ factor DNA ligase IV and Pso4 (Hromas et al. 2008, Beck et al. 2008). DNA ligase IV
mediates the final ligation step in NHEJ and Pso4 is a multifunctional protein that has been
implicated in RNA splicing and DNA repair. Both Metnase and Pso4 co-localize with Nbs1 at
DSBs and knockdown of Pso4 abrogated Metnase localization at DSB foci (Beck et al. 2008).
Thus interaction of Metnase and Pso4 may be essential for Metnase activity in DSB repair by
NHEJ. Since Pso4 has been implicated in repair of DNA cross links, it is also probable that
Metnase endonucleolytic activity may contribute to processing of such these lesions (Zhang et al.
2005). The SET histone methylase domain of Metnase directly mediated dimethylation of
H3K36 near induced DSB that was shown to promote association of NHEJ repair proteins
promoting DNA repair (Fnu et al. 2011). Whether the endonuclease function of Metnase also
contributes to DNA repair still needs to be investigated.
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Regulation of Metnase activity
Investigations into the regulation of Metnase activity has revealed that the protein is
phosphorylated in vivo following DNA damage. Metnase possesses two ATM/ATR consensus
sites, one Chk1/2 and p21 consensus sequence (Sequence surrounding S495) as well as a PKC
site where it can be potentially phosphorylated. However, two-dimensional gel electrophoresis
followed by phosphopeptide screening identified only one phosphopeptide that perfectly
matched the S495-containing domain. A S495A Metnase showed no phosphorylation in vivo
when expressed in HEK293 cell lines confirming that there may be only one phosphorylation site
on the protein (Hromas et al. 2012). This phosphorylation site is in the DDE-like transposase
nuclease domain and three-dimensional modeling suggests that phosphorylation could affect the
mobility of this otherwise flexible region thus affecting the nuclease function of the catalytic
triad. Metnase is primarily phosphorylated by Chk1 (8 fold greater than Chk2) and
dephosphorylated by phosphatase PP2A. HEK 293T cells expressing the S495A mutant were
unable to induce H3K36 dimethylation when compared with WT Metnase expressing cells by
western blot analysis. Interestingly, the S495A mutant showed increased restart of stalled
replication forks but decreased enhancement of DNA repair (Hromas et al. 2012). Thus the
authors of this work speculated that Chk1-mediated phosphorylation of Metnase at S295 may
regulate its DNA repair and stalled replication fork restart activities.
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2.4 Specific Aims
Resolution of oxidatively damaged chemically modified end-termini is a critical step in
repair of DNA-DSBs induced by radiation or radiomimetic chemotherapeutics. We have sought
to study the role of two candidate enzymes Artemis and Metnase in endonucleolytic removal of
such terminal blocking groups. Specifically we proposed
1. To determine the role of Artemis endonucleolytic activity in promoting
radio/chemoresistance.
Biochemical studies have shown that Artemis has a metallo-β-lactamase and a βCASP domain that promotes slow trimming of several bases from blunt DNA ends or
overhangs and resolves chemically modified 3ʹ-phosphoglycolate ends. At the same time
Artemis has been implicated in regulation of G2/M and S-phase cell cycle checkpoints
following DNA damage. In this thesis we have sought to establish the biologically
relevant role of Artemis by creating human fibroblast cell lines that express either D165N
mutant or wild type Artemis in Artemis-deficient cells obtained from a SCID patient and
corresponding normal cell lines. As reported below, survival and DSB repair assays were
performed using these cells, following exposure to ionizing radiation and radiomimetic
drugs. Co-immunostaining experiments revealed NHEJ factors that may play a role in the
repair of DSBs in an Artemis dependent pathway. Additional in vitro studies were also
performed to further characterize the chemically modified DSB ends that require
Artemis-mediated end processing.
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2. To investigate the effect of DNA end modifications on Metnase-mediated end
processing.
Metnase is a recently identified transposase which acts as a DNA DSB repair
factor that seems to promote in vivo end joining. Metnase has a methyltransferase domain
and an endonuclease domain that has been shown to cleave DNA near DSB ends.
Metnase knockdown confers about 2-fold radiosensitivity and decreases fidelity of repair.
On the other hand, Metnase overexpression has been shown to increase radiosurvival and
also increases precise NHEJ. It interacts with DNA ligase IV and increases both
efficiency and accuracy of DNA DSB repair. All these data suggest a possible role of
Metnase in resolution of terminally blocked DNA DSBs that has been investigated as part
of this thesis. Specifically, plasmid-length substrates with variously modified DNA ends
were designed that provided an in vitro system for investigation of end processing of
these DNA lesions by Metnase endonucleolytic activity. Additional studies were also
performed to characterize the interaction of Metnase with other NHEJ factors (Ku and
DNA-PK) affecting end joining.
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III.

MATERIALS AND METHODS

3.1 Cell lines and complementation
Normal 48BR and patient-derived Artemis-deficient CJ179 hTERT-immortalized human
fibroblasts originally from Dr. Penny Jeggo, were obtained from Dr. Lynn Harrison, Louisiana
State University, and were cultured in minimum essential medium (MEM-α) supplemented with
10% FBS and antibiotics (GIBCO). Cells were constantly maintained at 37°C in 5% CO 2 and a
humidified atmosphere. Normal Epstein-Barr virus-transformed human lymphoblastoid cells
(patient 1646) were from Dr. James Lupski, Baylor College of Medicine.
These obtained cell lines were complemented in Dr. Steven M. Yannone’s laboratory.
Lentiviral constructs were prepared in the 693-2 lentiviral backbone harboring the hygromycin
resistance gene (Campeau,E et al. 2009) carrying either wild-type or D165N mutant Artemis
cDNA fused to a c-myc epitope tag on the carboxyl terminus. Artemis wild type, D165N and
empty lentivector DNAs were transfected along with packaging plasmids, pLP1, pLP2 and pLPVSVG into 293FT cells with Lipofectamine 2000 (Invitrogen). Medium containing packaged
lentivirus was collected 48 hr post transfection, centrifuged 5 min at 1200 rpm in a clinical
centrifuge at room temperature. The supernatant was filtered through 0.45 µm filters (Novagen),
then ultracentrifuged at 20,000 RPM for 2.5 hr at 4°C in a SW28 rotor (Beckman). Resulting
viral pellets were resuspended with 200 µL of Hanks balanced salt solution and stored in 10 µL
aliquots at -80°C. The 48BR and CJ179 cell lines were seeded at approximately 75% confluence
in 25 cm2 dishes and incubated for 24 hr, then infected with 5 µL of concentrated lentivirus with
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4 µg/mL polybrene in 1 mL medium without serum for 8 hr, then fed with fresh medium and
incubated for 48 hr. Cells were then selected in medium containing 100 µg/mL hygromycin for 7
days. Cells were expanded under selection to produce cryogenic stocks and 2.5 x 10 6 cell
aliquots harvested and stored at -80°C as cell pellets for Western analysis.

3.2 Selection of Clones
From each derivative cell line, approximately 20 clones were isolated. 100 cells from
each cell line were plated on a 15 cm tissue culture dish and incubated for 8-10 days. The
separate colonies were identified under the microscope and marked. Sterile rings were put over
the colonies which were trypsinized and grown separately in 25 ml tissue culture flasks. Total
RNA was extracted from each clone using Qiagen RNeasy minikit and converted to cDNA using
high capacity RNA to cDNA kit (Applied Biosystems) following the protocols provided by the
manufacturer. Amplification of cDNA was performed on an ABI 7900HT Real time q-PCR
instrument using SYBR green (Applied biosystems). Relative Artemis levels were determined
after normalizing to β-actin levels using SDS 2.2.2 software. The primers used were
5′-ACAGAGCCTCGCCTTTGCCG-3′, 5′-CACCATCACGCCCTGGTGCC-3′ for β-actin and
5′-AGTACGGAGCCAAAGTATAAACCACT-3′, 5′-TCCGGGTATGGAACTTTGTGC-3′ for
Artemis cDNA amplification (Synthesized by IDT). Highest and lowest Artemis expressing
clones among those screened were identified and the protein levels were confirmed by
IP/western as described below. The selected clones were further used in survival/repair assays.

3.3 Immuno-precipitation and Western blots
Direct western blotting of cell lysates was attempted with a variety of antibodies to
Artemis but was found to be insufficiently sensitive and specific for Artemis detection; therefore,
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an immunoprecipitation step was added. For each cell line approximately 2.5 million cells were
harvested and sonicated on ice with three 30-second pulses in 750 µL of TBST (25 mM TrisHCL pH 7.4, 130 mM NaCl, 3 mM KCl, 0.1% (v/v) Tween 20) supplemented with 1 μM
leupeptin, 1 μM pepstatin A, and 1 μM aprotinin protease inhibitors (IP-buffer). Lysates were
cleared by centrifugation at 14,000 x g for 15 minutes at 4°C and supernatant incubated with
equilibrated protein A/G beads (Protein A/G UltraLink Resin, Thermo Scientific, prod#53132)
for 1 hr, then the extract was transferred to a new tube. Equilibration of the beads was performed
by first collecting the beads by centrifugation at 5000rpm for 30 sec, followed by removal of the
supernatant and washing 2 times with TBST (5000rpm, 30sec). The beads were then resuspended in IP-buffer to make up the original volume. Extracts were incubated with 1 µL of
SCIDA1024 rabbit antiserum (Wang et al. 2005) for 1 hr at 4°C, then 20 µL of equilibrated A/G
beads were added and tumbled overnight at 4°C. The A/G beads were pelleted in a microfuge at
5000 rpm for 30 sec at 4°C and washed three times with 500 µL IP-buffer. 50 µL Laemmli
buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris
HCl pH 6.8) was added to the washed beads and heated for 10 minutes at 98°C and centrifuged
at 14,000 x g for 15 minutes. Approximately 1 million cell equivalents of protein (20 µL) was
loaded onto 8% SDS-PAGE gels and resolved at 150 volts and transferred to a nitrocellulose
membrane with 100V for 90 minutes in methanol transfer buffer (25mM Tris, 192 mM glycine,
10% methanol), then incubated in TBST, 10% (w/v) powdered milk (blocking buffer), 1 hr at
22°C, with rocking. Membranes were probed with chicken IgY anti-human Artemis antibody
(Abcam, ab14289) at a 1:2000 dilution in 8 mL blocking buffer overnight at 4°C with rocking,
then washed in TBST 10 minutes x 3, and incubated in peroxidase-conjugated donkey antichicken IgY (H+L) (Gallus Immunotech Inc.,) at 1:5000 dilution in 8mL blocking buffer rocking
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for 1 hr at 22ºC then washed in TBST 10 minutes x 3 and developed with ECL plus (GE
Healthcare).

3.4 Cell Survival Assays
Confluent cells were further maintained in 0.5% serum for 5 days. The cells were then
irradiated (MDS Nordion Gammacell 40 research irradiator (ON, Canada), with a

137

Cs source

delivering a dose rate of 1.05 Gy/min) or treated with either 0.5, 1 or 2 μg/ml bleomycin (stock
concentration 2.5mg/ml) or 3, 6 or 12 nM neocarzinostatin (NCS) (stock concentration 1.2 μM)
for 4 hr. Following treatment, cells were washed with PBS and 500-20000 cells were seeded into
10 cm dishes in fresh medium. Cells were then incubated for 12 days before they were fixed with
methanol (100%) and stained with 1% crystal violet, rinsed with water and air-dried. Visible
colonies were counted manually.

3.5 Immunofluorescence
Cells were grown to confluence on tissue culture treated 4-well chamber slides (Nunc lab
tek, prod#154526) and further maintained at 0.5% serum for 24 hr. Cells were then either
irradiated (2 or 4 Gy) or treated with NCS (6 nM) for 1 hr. After treatment, cells were fixed by
incubating with 1 ml of 3% paraformaldehyde per well at room temperature (RT) for 15 min and
permeabilized with 0.5% triton X-100/PBS for 10 min/RT. The slides were then washed two
times with 1 ml PBS/well followed by blocking with 1 ml casein buffer (Bio-Rad, prod#1610783) for 3 hours/RT. Primary antibody was appropriately diluted in casein buffer, 0.3 ml was
added per well and was allowed to incubate overnight at 4ºC with rocking. When doing double
immunostaining, 0.3 ml of the second primary antibody was added at the same time as the first

48

antibody. Primary antibodies used for immunostaining were anti--H2AX (Upstate), anti-53BP1
(gift of Dr. David Gewirtz, Virginia Commonwealth University, originally from Dr. Thanos
Halazonetis, University of Geneva) at 1:500 dilution, anti-PML (PG-M3, Santacruz biotech) at
1:200 dilution, anti--H2AX rabbit polyclonal (Novus biologicals) at 1:400 dilution and
anti-hMre11 rabbit polyclonal (Novus biologicals) 1:200 dilution. The primary antibody was
then removed and the wells were washed 4 times with 1ml PBS for 15 min followed by
incubation with secondary antibody for 3 hours at RT. All secondary antibodies used were
obtained from Invitrogen molecular probes and used at 1:500 dilution in casein blocker. The
secondary antibodies were Alexa fluor 488 goat anti-mouse (γ-H2AX, 53BP1), Alexa fluor 568
goat anti-mouse (PML), Alexa fluor 488 goat anti-rabbit (γ-H2AX), Alexa fluor 568 goat
anti-rabbit (Mre11). After 4 × 15 min washes, the antibodies were fixed in place by treating with
1 ml 3% paraformaldehyde for 10 min. Paraformaldehyde was removed by 2 × 1 ml PBS washes.
Slides were then mounted with Vectashield mounting medium containing DAPI (4′,
6-diamidino-2-phenylindole). Images were captured using Olympus fluoview 500 confocal
microscope, using a 430-nm diode laser with a 605-nm band pass filter (DAPI), a 510-nm laser
with a 530-nm band pass filter (Alexa fluor 488) and a 660-nm laser with 605-nm band pass
filter (Alexa fluor 568). Foci from 100 cells were scored for each time point in 2-3 independent
experiments for each cell line. Focus diameter for the five largest foci in each cell was measured
in one direction parallel to the equatorial plane of the image field.

3.6 Fraction of activity released (FAR) DSB repair assay
Pulsed-field gel electrophoresis (PFGE) was used to quantify DSB repair as described
previously (Fouladi et al. 2000) with minor variations. Briefly, subconfluent cells were cultured
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on a 150-cm dish and labeled for 24 hr with 0.2 µCi/mL [methyl-3H] thymidine (20 Ci/mmole,
Perkin-Elmer). Confluence-arrested cells were serum-starved (0.5%) for 24 hr prior to irradiation.
After irradiation samples were incubated for noted repair times and then trypsinized and
resuspended in L buffer (0.1 M EDTA, 0.01 M Tris-Cl, 0.02 M NaCl) at a concentration of 2 x
107 cells/mL. 250 µL of this suspension was mixed with 250 µL of 2% low-melting agarose
(Nusieve GTG) in a 15-mL conical tube maintained at 45°C. About 60 µL of cell agarose
mixture was transferred to a sample CHEF disposable plug mold (Bio-Rad) and allowed to
solidify at 4°C. The plugs were removed and incubated in the digestion mixture (0.1 M EDTA,
0.01 M Tris-Cl, 0.02 M NaCl, 1% w/v Sarkosyl, 0.1 mg/mL proteinase K). The plugs were
incubated for 24 hr at 50°C with a change of digestion mixture after 3 hr. They were then washed
with TE (Tris-EDTA) over a period of 3 hr. The plugs were further incubated with 40 µg/mL
PMSF for 30 min at 50°C followed by 3 washes over a period of 3 hr. The plugs were inserted
into the wells of a 1% agarose gel (Bioline, DNA type grade) and separated in 0.5x TBE for 65
hr at 1.5 V/cm with switch times varying between 60 to 3600 seconds. The temperature was
maintained at 14°C throughout the run. Each lane of the plug was cut into 5 equal slices and each
slice was put into a separate scintillation vial. The slices were melted by autoclaving in liquid
cycle for 20 min. 15-20 ml of scintillation fluid (Biosafe II) was added and the fraction of
radioactivity released (FAR) from the plugs and remaining in the plugs was measured by liquid
scintillation. FAR is given as the ratio of total counts in the lanes (damaged DNA) to the total
counts in the lanes and the plugs (total DNA loaded onto the wells) expressed as a percentage.

3.7 Flow cytometric analysis of cell cycle
Cells were grown to confluence and further serum starved (0.5% serum) for 24 hours.
Control cells were neither serum starved nor confluent. Cells were then trypsinized, pelleted and
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the pellets were washed with PBS. The cell pellet was resuspended in 2 ml of 70% ethanol at 20ºC and kept at -20ºC for at least 3-4 hrs. Cells were then pelleted and washed two times with
PBS to remove all ethanol which may interfere with propidium iodide staining. The cell pellet
was resuspended in 200 μl of PBS. To this cell suspension, 5μl of RNase (10 mg/ml) and 10 μl
of propidium iodide (1mg/ml) were added followed by incubation at 37ºC for 30 min. The cells
were then pelleted and resuspended in 0.5ml PBS. The data were acquired using BD
FACScaliber flow cytometer and analyzed using the Modfit LT software.

3.8 Oligonucleotide purification
Oligonucleotides of various lengths were purchased from Integrated DNA technologies
Inc. and resuspended in molecular biology grade water (Sigma) to a concentration ranging from
250 μM to 500 μM. 400-500 pmoles of the oligonucleotide was 32P labeled and was subjected to
purification by 20% denaturing polyacrylamide gel electrophoresis. When purifying unlabeled
oligo, 10-20 nmoles were loaded onto the gel in SGLS (98% Formamide, 2% EDTA,
bromophenol blue) gel loading buffer.

3.9 Polyacrylamide gel electrophoresis
Polyacrylamide gels with acrylamide:bisacrylamide ratio of 20:1 and urea added to a
final concentration of 8 M were used for electrophoretic separations. The gel dimensions were
33.2cm X 38.5cm X 0.08cm. Urea was dissolved into the mixture at low heat and allowed to
cool down to room temperature before adding 0.075% (w/v) ammonium persulfate and 0.03%
(v/v) TEMED (Nʹ, Nʹ, Nʹ, Nʹ-tetramethylethylene diamine). The gel was allowed to set for
approximately 1 hour, following which the samples were loaded into the wells of the gel and
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electrophoresed at constant power of 40-60 watts for 4-6 hours in 1X TBE buffer. For the

32

P

labeled as well as unlabeled samples, short wave UV light (254 nm) was used to visualize the
bands that appear as greyish blue shadows on white paper in the dark. Phosphorylated
oligonucleotides (Oligos) which run faster than corresponding unphosphorylated starting oligos
were cut from the gel and eluted into 800 μl of 1 mM EDTA. To this, 800 μl of 0.2M
triethylamine was added, the mixture was filtered using a 0.45 μm filter and subjected to high
pressure liquid chromatography.

3.10 High Pressure Liquid Chromatography
The oligonucleotides to be used in various assays were further purified by reverse phase
high pressure liquid chromatography using a C18 column. Buffer A comprised of 5% acetonitrile
and 0.1 M triethylaamine while buffer B comprised of 50% acetonitrile and 0.1 M triethylamine.
Both buffers were adjusted to pH 7 using acetic acid or triethylamine. The column was
prewashed with buffers A and B for 10 minutes before beginning the run. A linear gradient was
used for purifying the oligonucleotides which increased from 5% buffer B to 30% buffer B over
a 60 min period at a flow rate of 1 ml/min. The peaks were detected with a UV detector in case
of unlabeled and a Geiger counter attached to the elution line for

32

P labeled oligos. Collected

volumes were then vaccum dried and dissolved in 1x TE (10 mM Tris-HCL, 0.1mM EDTA/pH 8)
buffer.

3.11 Trimming of pRZ56
Trimming of pRZ56 (pBR322 with a polylinker cloned into the tetracyclin-resistance
region) was done to generate a plasmid substrate with a ligatable end. First, 76 μg of pRZ56 was
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linearized in 300 μl of 1X buffer 3 (New England biolabs) using 100 units of MluI (pRZ56 has
single MluI site). Following incubation at 37ºC for 2 hours, 0.5 μl of was loaded onto a 0.8%
agarose gel and electrophoresed for 1 hr, stained with EtBr (Ethidium bromide) and visualized
under UV. If all the plasmid was cut, then linearized plasmid was precipitated by addition of 1/9
volume of 3 M NaOAc and 2.5 volume of 100% EtOH, at room temperature, centrifuged at
14000 rpm on a table top ultracentrifuge (Eppendorf) and washed with 70% ethanol to remove
excess salts. It was briefly dried in a Speed Vac (Savant) and resuspended in 100 μl of 1X TE
buffer and stored in -20ºC freezer. Ten micrograms of MluI-digested plasmid was used each time
for trimming reaction. Trimming was carried out in 35 μl reaction containing 5 units of T4 DNA
polymerase (NEB), 1mM dTTP and a buffer made up of 33 mM Tris acetate pH 8/ 66 mM
potassium acetate/ 500 μM DTT/ 100 μg/ml BSA at 11ºC for 2 hours. The reaction was stopped
by addition of 1.4 μl of 0.5 M EDTA to the reaction which was immediately extracted with 40 μl
of phenol. After centrifugation at 10,000 rpm for 10 min, the bottom layer was discarded. The
sample was again centrifuged for 1 min and the aqueous (top) layer was transferred to an
ethanol-washed tube, avoiding residue at the bottom. Then, 40 μl of chloroform was added to the
aqueous layer to remove the excess phenol, centrifuged for 5 min at 10,000 rpm and the bottom
layer discarded. The reaction was then brought to 3 M Ammonium acetate (Add 16 μl of 7.5 M
AmAc) and precipitated with 2.5 volumes of 100% EtOH. The pellet was resuspended in 45 μl
of molecular biology grade water and again precipitated with NaAc as described above. Finally
the pellet was washed with 170 μl of 70% EtOH and following air drying, was redissolved in 25
μl 1X TE.
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Various oligonucleotide modifications used in this thesis for substrate generation
CGAGGAACGC(oxoG)ACG (8-oxoG); CGAGGAACGCGACG-3ʹPG (14-PG)
CGAGGAACGCGAACG-3ʹPG (15-PG); CGAGGAACGCGAAAACG-3ʹPG (17-PG)
CGAGGAACGCGAAAAAAAAAAAA(LongA); CGAGGAACGCGTTTTTT(ShortT)
CGAGGAACGCGAAAAAA(ShortA), 3ʹ-PG is 3ʹ-phosphoglycolate ends
Figure 3-1. Method for generation of DNA substrates for in vitro nuclease assays. pRZ56
was cut with MluI and subjected to exonuleolytic digestion by T4 DNA polymerase in presence
of dTTP alone. This generated an overhang to which previously labeled, variously end-modified
substrates can be ligated. The internally labeled substrates were subjected to various nuclease
and enzyme assays and the products were analyzed on a 20% polyacrylamide gel.
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3.12 Construction of substrates with 3ʹ-PG terminated DSBs
Exonucleolytic digestion of pRZ56 by T4 DNA polymerase in presence of dTTP creates an
11 - base overhang to which oligos of desired length and end modifications were ligated to
generate various chemically modified and corresponding normal ended substrates mimicking
DSBs in cells. To generate a 3-base 3ʹ-overhang substrate, a 3ʹ-PG 14-mer (14-PG) was ligated
into the 11-base gap that was created by the controlled digestion earlier. For the ligation 5 μg
(1.5 pmole) of of pRZ56 was added to 5 pmoles of the oligo in 1X One-Phor-All (10 mM tris
acetate, 10mM Magnesium acetate, 50 mM potassium acetate, Pharmacia biotech, pH 7.4) was
added to 40 μl of the reaction which was carried out in the presence of 60 units of T4 DNA
ligase. Sodium chloride was added to 150 mM and ATP to 2 mM. In later studies the ligations
were performed in 1X DNA ligase buffer (New England Biolabs). Overnight incubation was
carried out at 16ºC followed by 15 min incubation at 65ºC to inactivate the ligase. The ligation
product was then loaded onto a 0.8% agarose gel which was run in 1X TBE buffer with 0.5
μg/ml EtBr. The gel was run at 100 V for 2 hours, visualized under UV, the band corresponding
to the plasmid DNA was excised and subjected to electroelution.

3.13 Electroelution of the modified substrate
A pretreated dialysis tubing of about 10 inch was cut and tied at one end. The tube was
then filled with a buffer containing 20 mM Tris, pH 8 and 1 mM EDTA (Elution buffer), the gel
was placed in the tubing and the other end knotted carefully to remove any air bubbles. The
tubing was placed in a electroelution apparatus filled with the same buffer and eluted overnight
at 30 V with the buffer circulating between both the reservoirs. Following completion of the
elution, the potential (Leads) were reversed for 1 minute to release the DNA stuck to the tubing
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wall into the buffer. The dialysis bag was carefully cut open and the buffer containing DNA
substrate was removed into 15 ml centrifuge tubes. The solution was filtered through a 0.45 μm
filter to remove any debris and was concentrated by micro-concentration to about 250 μl using
centricon-100 (Amicon). The concentrate was collected by pipetting into a 1.5 ml
microcentrifuge tube and precipitated using 1/9 volume of NaOAc and 2.5 volume of 100%
EtOH as described previously. The precipitate was washed with 70% EtOH and following drying
was reconstituted in 50 μl 1X TE.

3.14 Construction of 8-oxoguanine-containing substrates
The protocol described above for preparation of 3ʹ-PG containing substrates was
modified for preparation of substrates bearing 8-oxoguanine (8-oxoG) to prevent oxidation and
degradation of the 8-oxoG residue during the purification process. The 8-oxoG residuecontaining 14 mer with a sequence CGAGGAACGC(8-oxoG)ACG was obtained from the
Midland Certified Reagent Company, Inc. It was dissolved in 200 μl of 10 mM HEPES
(Hydroxyethyl piperazineethanesulfonic acid) buffer / 1 mM EDTA buffer, pH 8 at a final
concentration of 1.17 mM oligo. 20 pmoles of the 8-oxoG oligo was labeled with [γ-32P] ATP (5
μl of 0.151 mCi/μl) using T4 PNK in a 12.5 μl reaction for 1 hour at 37ºC. The reaction was
extracted with 12.5 μl of Phenol/chloroform as described above. To 4 pmoles of the labeled 8oxoG oligo, 5 μg of trimmed pRZ56 plasmid was added followed by precipitation with 1/9
volume of NaOAC and 2.8 volume of EtOH as previously described and briefly dried in the
speed vac. The dried pellet was resuspended in either 1X One-Phor-All buffer (supplemented
with ATP) or 1X T4 DNA ligase buffer to a total volume of 70 μl and was ligated with T4 DNA
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Figure 3-2. Method for generation of thymidine glycol containing substrate for Artemis
nuclease reactions. A new method was devised to generate DNA substrates that allows
manipulation of both strands to mimic DNA DSBs with modified ends in vivo. PUC19 was first
double digested with BsaI and ScaI to generate noncomplementary 5ʹ-overhangs and blunt ends.
The 406 bp fragment released following ScaI digestion was removed by gel purification. To this,
previously labeled duplex oligonucleotide having the sequence shown was ligated and the
ligation product was further purified as described in the text. The ligation of the duplex
oligonucleotide with the ligatable end generated a BsrDI site that was used to release the end
termini for analysis in biochemical assays.
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ligase as described for 3ʹ-PG containing substrates. The plasmid was precipitated with 7.5 M
AmAc (53.5 μl), water (30 μl) and 2.5 volume EtOH (575 μl) (leaving most of the oligo in
solution), washed and resuspended in 50 μl water. The ligated DNA substrate was then purified
by using Qiaquick spin columns using PCR purification protocol (Qiagen) and eluted in 30 – 50
μl of elution buffer and stored at -80ºC. The recovery of the ligated product varied from 0.5 μg –
1.2 μg.

3.15 Construction of Thymidine glycol containing substrate
PUC19 was transformed into E.coli (alpha-gold from Bioline) and purified using Qiagen
Plasmid Midi Kit according to the manufacturer’s protocol and analysed on a 0.8% agarose gel
to ascertain purity. Concentration was measured on a UV spectrophotometer at 260 nm
wavelength. Twenty microgram of pUC19 was double digested with 60 units of BsaI and ScaI
(NEB) in a total volume of 130 μl in buffers provided by the manufacturer. The digestion was
continued for two hours and 0.5 μl aliquot was analyzed by agarose gel electrophoresis as
described. In case of incomplete digestion, the reaction was continued for another two hours.
Thymidine glycol oligo with a sequence 5ʹ-ACCGCGAGACTCACGCTCA(ThyGly)ACG-3ʹ
was obtained from Midland Certified Reagents and dissolved in 1X TE to a final concentration
of 250 μM. About 750 pmoles of the thymidine glycol containing oligo was then labeled with
γ-32P-ATP, electrophoresed to separate it from unphosphorylated oligo and HPLC purified.
Twenty five pmoles of it was then annealed to HPLC-purified (Method described above) partial
complementary oligo with sequence 5ʹ-ATGAGCGTGAGTCTCG-3ʹ (IDT) by first heating to
80ºC followed by slow cooling to 16ºC. The BsaI/ScaI double digested pUC19 (4 μg) was then
ligated to the annealed oligo (4 pmoles) and purified as described for the 3ʹ-PG substrates.
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Corresponding normal substrate bearing thymidine instead of the modified thymidine glycol was
prepared similarly.

3.16 Artemis nuclease assays
Full length Artemis protein was purified from SF9 insect cells infected with recombinant
baculovirus generated by subcloning Artemis cDNA into pFASTBAC-HT (Invitrogen). Ku70/80
was purified from insect cells coinfected with a mixture of recombinant baculovirus harboring
the human Ku70 and Ku80 genes, and DNA-PK was purified from Hela cells as described
(Povirk et al. 2006). These purified proteins were obtained from Dr. Steven M. Yannone. Each
nuclease reaction was typically 10 μl, containing 25 mM Tris-HCL, pH8, 25 mM NaCl, 10 mM
MgCl2, 1 mM DTT, 0.25 mM ATP and 50 μg/ml BSA . To this reaction mixture 10 ng of the
labeled DNA substrate (8-oxoG/ThyGly) was added and mixed by pipetting. Ku (25 nM) and
DNA-PK (65 nM) was then added to the reaction followed immediately by Artemis (90 nM).
The reaction was then mixed by pipetting (Avoid vortexing) and placed in a 37ºC bath for 10, 30,
60 or 120 min. The control reactions (where Artemis was excluded) were incubated for 60 min.
All the reactions were stopped by addition of 20 μl of 10 mM EDTA, 0.45 M NaOAc and 100
μg/ml tRNA, followed immediately by Phenol/chloroform extraction and ethanol precipitation.
The pellet was washed with 70% ethanol and dried. DNA was then cut with AvaI at 37ºC for 4
hrs in 40 μl of the buffer supplied by the vendor. Following digestion, 1/9 volume of NaOAc
was added to each reaction which was then ethanol precipitated and was further washed with 70%
ethanol. Vaccum dried pellet was dissolved in 10 μl of formamide containing 20 mM EDTA and
analyzed by 20% PAGE. Quantification was done by using ImageQuant 5.1 densitometry
software.
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3.17 Metnase nuclease reactions
The human FLAG-Metnase purified from HEK 293 cells as described (Roman et al. 2007)
was obtained from Dr. Suk-Hee Lee. Reaction mixtures (10 μl) containing 25 mM Tris-HCL,
pH8, 25 mM KCl, 10 mM Mg(Ac)2, 5 mM DTT, 0.25 mM ATP and 50 μg/ml BSA were
prepared. To this reaction mixture 10 ng of variously modified DNA substrates were added. The
substrates used were 12-PG (1-base 3ʹ-overhang), 14-PG (3-base 3ʹ-overhang), 15-PG (4-base 3ʹoverhang), 17-PG (6-base 3ʹ-overhang) and 8-oxoG (3-base 3ʹ-overhang, 8oxoG modification at
the last paired base). Oligomeric single stranded substrates with 3ʹ-phosphotyrosine and 3ʹ-biotin
were also used in the reactions as indicated. This was followed by immediate addition of 20, 50
and 100 nM Metnase to the reaction which was mixed by pipetting and incubated at 37ºC for 2
hours. Reactions performed following addition of 50 nM Metnase were incubated for 4 hours at
37ºC. All reactions with either plasmid or oligomeric substrates were stopped by addition of 20
μl of 10 mM EDTA, 0.45M NaOAc and 100 μg/ml tRNA, followed immediately by
Phenol/chloroform extraction and ethanol precipitation. In some cases the pellet was resuspended
in 0.25 mM CoCl2 and 1X Terminal transferase buffer and the samples were treated with 12
units of terminal transferase in presence of 250 μM ddTTP. Plasmid DNA substrates were then
cut with either AvaI (30 units, 37ºC for 4 hrs) or TaqαI (30 units, 65 ºC for 4 hrs) in 40 μl of the
buffer supplied by the vendor, ethanol precipitated, dissolved in 10 μl of formamide containing
20 mM EDTA and analyzed by 20% PAGE. In case of oligomeric substrates the plasmid
digestion steps were omitted.

3.18 DNA footprint analysis
To assess the accessibility of DNA ends, an internally labeled substrate (10 ng) with a 12base 3ʹ-overhang was incubated with 25 nM Ku and 65 nM DNA-PK in buffer containing 25mM
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Tris-HCL, pH8, 25 mM KCl, 10 mM Mg(Ac)2, 5 mM DTT and 50 μg/ml BSA for 20 min. Then,
S1 nuclease (Invitrogen, 980U/μl) was diluted to 10 U/μl in S1 nuclease dilution buffer provided
by the manufacturer and 0.3 U of the enzyme was added to 10 μl reaction and incubated at 25ºC
for 5 mins. The reaction was stopped by adding 20 μl of 10mM EDTA, 0.45M NaOAc and 100
μg/ml tRNA, followed immediately by phenol/chloroform extraction and ethanol precipitation.
The reaction was analyzed on 20% PAGE.

3.19 Statistics
Error bars represent standard error of mean (SEM) for at least three independent
experiments or standard deviation (SD) for two experiments. In certain cases, unpaired two tailed
t-tests were performed using Sigmaplot and the data was reported as significant for P values
<0.05.
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IV. RESULTS

4.1 Generation of wild type and D165N mutant Artemis expressing cell lines.
Radiosensitive severe combined immunodeficiency (RS-SCID) is an autosomal
recessively inherited genetic disorder that can result from several different causative mutations in
DCLRE1C gene leading to functionally null Artemis mutants (Pannicke et al. 2010, Kobayashi
et al. 2003). Several cell lines have been established from such patients and have been used
extensively in the literature for studying Artemis functions in V(D)J recombination and DNA
repair (Riballo et al. 2004, Beucher et al. 2009).
Patient-derived CJ179 cells (human fibrobalsts) and corresponding normal 48BR cells
were obtained from Dr. Penny Jeggo and complemented with either wild type (WT) or D165N
mutant Artemis using lentiviral vectors by Dr. Steven M. Yannone. First, Artemis expression
levels were evaluated by Western blots of Artemis immunoprecipitated from extracts of the
complemented and mock-complemented lines (Fig. 4-1). The levels of lentiviral-mediated
Artemis expression are similar for the two alleles and expression was much greater than that of
endogenous Artemis in normal cells, which was below the level of detection by western blot.
However, the presence of an Artemis transcript in normal 48BR cells was verified by real time
qPCR (Fig. 4-2) followed by agarose gel electrophoresis that showed a product of the expected
size
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cells

(Fig

4-3).

Figure 4-1. Expression levels of wild-type and D165N mutant Artemis in
complemented Artemis-deficient CJ179 cells (CJ Arte+, CJ Endo-), and in 48BR
normal fibroblasts (48BR Arte+, 48BR Endo-). CJ Vect and 48BR Vect are the
respective empty-vector-infected cell lines. Artemis was immunoprecipitated using rabbit
polyclonal anti-hArtemis antibody and immunoblotted using chicken polyclonal IgY antihArtemis (Abcam). Endogenous Artemis in 48BR cells is below the level of detection.
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Figure 4-2. Amplification plot for detection of Artemis transcript. Total RNA was isolated
from the mentioned cell lines and subjected to cDNA synthesis. Exon spanning primers were
used to amplify Artemis or β-Actin cDNA. PCR was conducted in an Applied Biosystems
9700HT system with a thermal profile consisting of 2 min at 50ºC and 10 min at 95ºC, followed
by 40 cycles of 15 sec at 95ºC and 1 min at 60ºC.
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Figure 4-3. Normal human fibroblasts (48BR) express low levels of Artemis
transcript. Artemis cDNA from Normal (48BR Vect) and Hela cells were amplified
using real time q-PCR as described for 40 cycles. 10 μl from a 25 μl reaction was run on
3% agarose gel with hyperladder 4 (Bioline) as reference. A specific amplification
product 137 bp long was detected for both Hela and 48BR Vect cells but not in CJ179
Vect cells.
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Figure 4-4 (A). Representative FACS plots of Artemis-deficient human fibroblasts
showing G1 arrest. Various cell lines (CJ179) were confluence arrested and serum
starved (0.5% serum for 5 days) to synchronize them in G1 phase of cell cycle. Flow
cytometric analysis to confirm cell cycle arrest was performed following propidium iodide
staining. Data were analysed using Modfit LT software. 90-95% cells were arrested in G1
phase of cell cycle for all cell lines.
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Figure 4-4 (B). Representative FACS plots of normal human fibroblasts showing G1
arrest. Various cell lines (48BR) were confluence arrested and serum starved (0.5%
serum for 5 days) to synchronize them in G1 phase of cell cycle. Flow cytometric analysis
to confirm cell cycle arrest was performed following Propidium iodide staining. Data
were analysed using Modfit LT software. 90-95% cells were arrested in G1 phase of cell
cycle for all cell lines.
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Figure 4-5. Radio/chemosensitivity of Artemis deficient and D165N Artemis
mutant fibroblasts. Clonogenic survival assays were performed on confluence- arrested
serum-starved cells treated with bleomycin (A), neocarzinostatin (B) and radiation (C).
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4.2 D165N mutant Artemis fails to rescue chemo/radiosensitivity.
Previous in vitro studies have shown that in the presence of DNA-PK, Artemis has
endonucleolytic activity toward both the 3′ and 5′ termini of DNA ends (Yannone et al. 2008, Ma
et al. 2002). This endonucleolytic activity may facilitate the slow processing of 3′-PG-terminated
blunt ends by Artemis/DNA-PK (Povirk et al. 2007). To investigate the biological relevance of
Artemis endonucleolytic activity, confluence-arrested, serum-starved (0.5% serum, 5 days),
wild-type and D165N mutant Artemis expressing patient-derived CJ179 cells, as well as normal
48BR cells were exposed to radiation, bleomycin, and neocarzinostatin (NCS). These agents are
known to induce free radical-mediated DSBs of diverse structure, many of which bear 3′-PG
termini (Henner et al. 1983, Povirk 1996, Dedon, Goldberg 1990). Due to confluence and serum
starvation, 90- 95% of the cells used in survival assays showed G1 arrest, thus increasing their
dependence on NHEJ (Fig 4-4 A, B). In all cases the Artemis-deficient CJ179 fibroblasts showed
significant hypersensitivity to -irradiation, bleomycin, and NCS (Fig. 4-5), as reported
previously for other, unrelated Artemis-deficient cell lines (Povirk et al. 2007). Complementation
with wild-type Artemis but not D165N mutant Artemis rescued this sensitivity. Furthermore, this
overexpression of wild-type Artemis increased the chemo/radioresistance of normal 48BR cells,
as compared to that of 48BR cells carrying the empty vector. Taken together, these results
suggest a direct role of Artemis endonucleolytic activity in resolution of DNA DSBs following
irradiation or radiomimetic drug treatment.

4.3 Endonucleolytic activity of Artemis is essential for DNA DSB rejoining in cells.
To directly evaluate the role of Artemis’ endonuclease activity in DSB repair, γ-H2AX
and 53BP1 foci were quantified as a measure of residual DNA DSBs in Artemis-deficient or
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Figure 4-6. Resolution of γ-H2AX foci in Artemis deficient and D165N mutant
Artemis cell lines. Immunostaining was performed for phosphorylated γ-H2AX
following exposure to 2 Gy γ-radiation for the wild-type/D165N mutant Artemis
expressing cell lines and the repair was followed at indicated times. Representative
images for data quantified in Fig 4-7A are shown.
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Figure 4-7. Dependence of cellular DSB rejoining on Artemis endonucleolytic
activity. (A) γ-H2AX foci were scored in confluence-arrested serum-starved cells
following 2 Gy γ-irradiation, and the results plotted as number of foci/cell. (B) 53BP1
foci were scored following 4 Gy γ-irradiation. (C) γ-H2AX foci were scored as in (A)
following treatment with 6 nM NCS for 1 h. Error bars represent the SEM from three
independent experiments except for (B), which shows data from two experiments.
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Figure 4-8. Co-localization of γ-H2AX and 53BP1 following exposure to 2 Gy
γ-radiation. Green fluorescence: 53BP1 (Monoclonal anti-53BP1 antibody, Dr.
Gewirtz’s lab). Red fluorescence: γ-H2AX (Polyclonal anti- γ-H2AX antibody, Novus
biologicals). About 70% of γ-H2AX foci merge with 53BP1 foci. This indicates that
there is 30% less induction/detection of 53BP1 foci than γ-H2AX foci in cells.
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Figure 4-9. Fraction activity release assay showing DSB repair defect in Artemis
deficient and D165N mutant Artemis cell lines. (A) PFGE was performed on DNA from
confluence-arrested serum-starved normal (48BR) or Artemis-deficient (CJ179) cells that
were complemented with wild-type or D165N mutant Artemis. Cells were irradiated and then
incubated for the indicated times (in hours) to allow repair before analysis by PFGE. (B) FAR
values were plotted after subtraction of the FAR value for unirradiated cells. PFGE
experiments with NCS were precluded by the large amount of drug required.
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proficient cell lines following irradiation or NCS treatment. γ-H2AX is a well-established and
sensitive marker that becomes phosphorylated at a conserved C-terminal SQ site within minutes
of exposure to ionizing radiation (Rogakou et al. 1998) and radiomimetic drugs. Phosphorylated
H2AX is believed to recruit other repair and cell cycle control factors such as MRN complex and
53BP1 to the sites of DNA DSBs to facilitate repair.
These assays were performed using non-replicating G0/G1 cells to avoid spontaneous
focus formation at stalled replication forks. The formation and loss of γ-H2AX and 53BP1 foci
was similar in all cell lines at 30 min and 2 hr post irradiation. However, at 6-18 hr, a significant
fraction of foci were seen to persist in Artemis-deficient CJ179 fibroblasts, while nearly all of the
foci resolved in normal 48BR cells (Fig. 4-6, 4-7). A stable complementation with wild-type
Artemis was able to correct this defect to normal levels while the D165N mutant Artemis
completely failed to rescue the DSB repair defect of CJ179 cells, suggesting that this process
requires Artemis endonucleolytic activity. Essentially identical complementation results were
obtained in cells treated with NCS (Fig. 4-7C). Although the kinetics of γ-H2AX and 53BP1 foci
were nearly identical, a higher dose of radiation was required to induce a comparable number of
53BP1 foci. Staining with a mouse monoclonal antibody to γ-H2AX confirmed that some
γ-H2AX foci did not contain detectable 53BP1, as has been previously reported (Van Vugt et al
2010) (Fig. 4-8).
The above results were confirmed by a PFGE assay that measures DSBs directly but
requires use of higher doses of radiation (40 Gy, Fig. 4-9). Again, 10-20% of the DSBs remained
unrejoined in Artemis-deficient and D165N mutant-complemented CJ179 cells, indicating that
repair of this subset of DNA DSBs require Artemis endonucleolytic activity even at these higher
doses.
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4.4 Low-level Artemis expression is sufficient to restore radiosurvival
A possible concern for these studies, as well as earlier studies using transient expression
from transfected plasmids (Beucher et al. 2009), is that the levels of Artemis transgene
expression are much higher than endogenous levels in normal fibroblasts, thus bringing into
question the physiological significance of such expression. Thus, to assess the possible effect of
Artemis expression levels on survival and repair, clones having the highest/lowest level of
Artemis expression among those screened were isolated from 48BR and CJ179 cells transduced
with vectors encoding WT or D165N Artemis.
Artemis expression levels were first determined by real time q-PCR and confirmed by
IP/western analysis. All transgene-expressing clones produced detectable levels of Artemis
protein, which correlated with the levels of Artemis mRNA. While the Artemis levels in all
clones were still higher than in 48BR and other normal fibroblasts, they were comparable to and
in some cases lower than the endogenous level in normal lymphoblastoid cells (Fig 4-10A, B).
Moreover, the CJ179 clone expressing the lowest level of WT Artemis was as radioresistant and
as repair proficient as the highest-expressing clone (showing sevenfold higher expression by
q-PCR), and both were more radioresistant than normal 48BR-Vect cells (Fig 4-11B, C). In
contrast, even high levels of Artemis D165N expression (~8-fold higher than the level in CJ
Arte+clone 1 by q-PCR; Figure 4-10A) conferred no detectable radioresistance (Figure 4-11B).
Overall, these results suggest that a modest amount of WT Artemis is sufficient to correct
the repair defect in Artemis-deficient cells and increase radioresistance, and that the restoration
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Figure 4-10. Wild type/D165N Artemis expression levels in various isolated clones.
(A) Artemis cDNA was amplified using real time q-PCR and the relative quantities of
Artemis expression for indicated clones (cln) using normal lymphoblastoid cells as
calibrator sample and β-actin as endogenous control are plotted. Error bars indicate SEM
for 3 independent experiments. All 20 isolated CJ Endo - clones had similar levels of
expression. (B) Artemis protein level for selected clones was verified by IP/Western blot.
JRL2 are normal lymphoblastoid cells.
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Figure 4-11. Effect of wild-type/D165N Artemis expression levels on radiosurvival
and repair. Clonogenic survival assays were performed on confluence-arrested serumstarved clones following exposure to radiation. The data points for CJ Vect and 48BR
Vect are same for (A) and (B). Error bars represent SEM for three independent
experiments. (C) γ-H2AX foci were scored in confluence-arrested serum-starved
high/low wild-type Artemis-expressing CJ179 cells. Error bars represent standard
deviation for two independent experiments.
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of radioresistance is dependent on Artemis-mediated endonuclease activity and is not an artifact
of overexpression.

4.5 Persistent radiation-induced foci in Artemis-deficient cells grow larger with time and
juxtapose with PML-nuclear bodies.
In addition to a larger number of persistent foci, cells lacking functional Artemis showed
a significant time-dependent increase in the average diameter of the residual foci, from
approximately 0.8 μm at 30 min to 1.4 μm at 12-18 hr (Fig. 4-12A, B, C). This increase was seen
for both 53BP1 and γ-H2AX foci, and for both Artemis-deficient and Artemis D165Ncomplemented cells. These results provide further evidence that the hypersensitivities in these
cells are due to defective repair processes. Moreover, these results suggest that the unrepaired
DSBs promote persistent ATM activation and continued accumulation of repair factors like
Mre11 (Fig. 4-13A, B and C) in the vicinity of the break site.
Promyelocytic leukemia protein (PML) is a tumor suppressor that along with Daxx, SP
100 and CBP has been identified as the main constituent protein within subnuclear compartments
also referred to as nuclear bodies (NBs) (Carbone et al. 2002, Weis et al. 1994). PML is
phosphorylated by ATM (Lallemand-Breitenbach, de Thé 2010) and PML-NBs have also been
shown to co-localize with Mre11 and p53 at the sites of radiation induced foci (Carbone et al.
2002) at later time points.
To investigate whether PML NBs and associated proteins may be recruited to the residual
DNA DSBs, PML and γ-H2AX interaction was analyzed in cells by double immunostaining and
confocal microscopy. As shown in Fig. 4-14, a subset of PML NBs were found to be juxtaposed
to the residual DNA DSBs in Artemis-deficient cell lines at later time points of 12 -18hr. These
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Figure 4-12. (A) Growth of persistent radiation-induced foci in Artemis-deficient
cell lines. Confocal microscopy of Artemis-deficient and D165N mutant-complemented
CJ179 fibroblasts, showing increase in the size of γ-H2AX foci that persist 12–18 h postirradiation. Arrows are pointing towards large foci.
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Figure 4-12. Growth of persistent radiation-induced foci in Artemis-deficient cell
lines. (B) Average size of 53BP1 (dose of 4 Gy) or (C) γ-H2AX (dose of 2 Gy) foci.
Focus diameter on fluoromicrographs was measured in one direction parallel to the
equatorial plane of the image field. The error bars represent SEM for 35 foci.
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Figure 4-13. (A) Mre11 and γ-H2AX co-localization following exposure to 2 Gy
γ-radiation in CJ Arte+ cells. Double Mre11 : γ-H2AX staining was performed after
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Arte+ are shown.
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence:
Mre11 (Polyclonal anti-hMre11 Novus biologicals).
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Figure 4-13. (B) Mre11 and γ-H2AX co-localization following exposure to 2 Gy
γ-radiation in CJ Vect cells. Double Mre11:γ-H2AX staining was performed after
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Vect are shown.
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence:
Mre11 (Polyclonal anti-hMre11 Novus biologicals).
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Figure 4-13. (C) Mre11 and γ-H2AX co-localization following exposure to 2 Gy
γ-radiation in CJ Endo- cells. Double Mre11:γ-H2AX staining was performed after
paraformaldehyde fixation. Confocal analysis of representative cell, CJ Endo- are shown.
Green fluorescence: γ-H2AX (monoclonal anti γ-H2AX, Millipore); red fluorescence:
Mre11 (Polyclonal anti-hMre11 Novus biologicals).
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Figure 4-14. PML and γ-H2AX partial co-localization and juxtapositioning after 2
Gy γ-radiation exposure. Double PML/γ-H2AX staining was performed after
paraformaldehyde fixation. Confocal analysis of representative cells is shown. Green
fluorescence: γ-H2AX (polyclonal anti γ-H2AX, Novus biologicals); red fluorescence:
PML (monoclonal anti-PML, Santa Cruz, PGM-3). IR Ctrl=no irradiation.
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results indicate that such positioning occurs even at relatively low levels of initial DNA damage,
as long as there are a significant number of residual foci.

4.6 Overexpression of D165N mutant Artemis renders normal cells repair-deficient.
If, as proposed, the primary role of Artemis in chemo/radioresistance is endonucleolytic
trimming of DSB ends, then overexpression of mutant Artemis might be expected to displace the
normal enzyme and prevent such trimming. A D37N-413aa C-terminal truncated Artemis
overexpression has recently been shown to increase radiosensitivity and induce repair defect in
tumor cell lines. However, since the mutant protein is both phosphorylation-deficient (due to
deletion of C-terminal regulatory region) and endonuclease deficient (D37N) it is difficult to
conclude which activity of the protein leads to this dominant negative effect (Liu et al. 2011).
At 2 Gy, or at equally toxic concentrations of bleomycin or NCS, no such dominantnegative effect was seen in our experiments, as D165N-overexpressing 48BR cells were as
chemo/radioresistant as empty-vector controls (Fig. 4-16A, B and C), and were fully competent
in resolution of repair foci (2 Gy, Fig. 4-15A). However, in FAR assays, overexpression of
D165N mutant Artemis conferred upon normal fibroblasts a slight repair defect at high doses of
γ-radiation (40 Gy, Fig. 4-15B), indicating that when the repair system is saturated with DSBs
(40 Gy exposure is predicted to result in 1600 DSBs compared to 80 DSBs at 2 Gy), the
probability of the end termini being occupied by D165N mutant Artemis is more than that of the
endogenous protein. Conversely, overexpression of wild-type Artemis rendered normal cells
more resistant to γ-radiation (Fig. 4-16A) and chemotherapeutic drugs bleomycin (Fig. 4-16B)
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Figure 4-15. Overexpression of D165N mutant Artemis confers high-dose DSBrepair deficiency. (A) γ-H2AX focus assay was performed after 2 Gy γ-irradiation. (B)
PFGE analysis of normal fibroblasts overexpressing wild-type or D165N mutant Artemis
after exposure to 40 Gy γ-rays. The panel displays FAR versus repair time (for 48BR Vect
versus 48BR Arte+ P>0.3 at all times; for Vect versus Endo- P=0.04 at 12 h and P=0.16 at
18 h, by t-test).
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Figure 4-16. Overexpression of D165N Artemis has no effect on
radio/chemosensitivity of normal 48BR fibroblasts (A) Clonogenic survival was
determined following treatment with radiation (for Vect versus Arte+ P=0.04 at 4 Gy and
P=0.07 at 6 Gy; for Vect versus Endo- P>0.3 at all doses). Vect cells are empty-vector
controls. The data for 48BR Vect and 48BR Arte+ are same as shown in Figures 4-5, and
are shown here separately for the sake of clarity and comparison with 48BR Endo-. (B, C).
Clonogenic survival was determined following treatment with bleomycin, or
neocarzinostatin. Although survival of 48BR Endo‾ cells was slightly lower than that of
Vect cells following bleomycin treatment, the difference was not statistically significant.
For bleomycin treatment, p = 0.56, 48BR Vect vs 48BR Endo‾ (1μg/ml, t test), p = 0.49,
48BR Vect vs 48BR Endo‾ (2μg/ml, t test). For NCS treatment, p = 0.62, 48BR Vect vs
48BR Endo‾ (3nM, t test), p = 0.93, 48BR Vect vs 48BR Endo‾ (6nM, t test).
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and neocarzinostatin (Fig. 4-16C) suggesting that an excess of wild type Artemis in cells adds to
the survival advantage following genotoxic insult. But such an overexpression of WT Artemis
but did not produce a detectable change in repair, with all measurable DSBs being rejoined
within 12 hr according to both focus-formation (Fig. 4-15A) and FAR assays (Fig. 4-15B).

4.7 8-oxoguanine residue stimulates and thymidine glycol inhibits KU- and DNA-PKmediated Artemis activity.
The most lethal DNA DSBs are those that have a high structural complexity and thus are
resolved with slow repair kinetics (Riballo et al. 2004). High-LET radiation has been suggested
to induce such complex DNA DSBs, which also comprise a subset of DSBs induced by low-LET
radiation. These complex DSBs are defined as multiply damaged sites consisting of a DSB with
varied end morphology and flanking base damage (Asaithamby, Chen 2011). The most
commonly found base damage associated with a DSB is 8-oxoguanine and thymidine glycol, due
to their lower oxidation potential. Such oxidized bases are usually repaired by base excision
repair, however it was recently shown that an 8-oxoguanine residue in close proximity
to a DSB is a poor substrate for the base excision repair mechanism (Dobbs et al. 2008).
Moreover, a base damage immediately upstream of a DNA DSB had a severe inhibitory effect on
non-homologous end joining (Datta et al. 2011), indicating that these lesions might be
preferentially repaired by the alternate ATM-and Artemis-dependent NHEJ pathway that is
implicated in the slow repair of more complex DNA DSBs. Two different internally labeled
substrates were used to determine whether the endonucleolytic activity of Artemis was affected
by the presence of an 8-oxoguanine or a thymidine glycol moiety. The internally labeled
plasmid-length substrates were designed to contain 8-oxoguanine or thymidine glycol as
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Figure 4-17. 8-oxoguanine residue stimulates DNA-PK dependent Artemis
endonucleolytic activity. (A) An internally labeled plasmid substrate bearing an 8-oxoG
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal
substrate were treated with Artemis (90 nM), DNA-PK (65 nM) and Ku (25 nM) as
indicated. Following digestion of treated plasmid with AvaI for 2 hrs, the released end
was analyzed by 20% PAGE under denaturing conditions. The numbers to the right
indicate the number of nucleotides resected from the 3ʹ-end. The overall kinetics of
cleavage were measured as a function of time (10-120min) for the complete reaction. For
all other reaction, the time of incubation was 60 min.
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Figure 4-17. 8-oxoguanine residue stimulates DNA-PK dependent Artemis
endonucleolytic activity. Artemis activity towards resection of 2-nt (B), 3-nt (C), 4-nt
(D) and 5-nt (E) is quantified for the 8-oxoguanine and corresponding normal substrate.
Error bars represent SEM of three independent experiments.
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Figure 4-18. Thymidine glycol blocks Artemis-mediated end-trimming. (A) An
internally labeled plasmid substrate on pUC19 backbone bearing a thymidine glycol
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal
substrate were treated with Artemis (90 nM), DNA-PK (65 nM) and Ku (25 nM) as
indicated. Following digestion of treated plasmid with BsrDI at 65ºC for 2 hrs, the
released end was analyzed by 20% PAGE under denaturing conditions. The overall
kinetics of cleavage was measured as a function of time (10-120min) for the complete
reaction. For all other reactions, the time of incubation was 60 min.
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B

Figure 4-18. Thymine glycol blocks Artemis-mediated end-trimming. (B) Kinetics of
Artemis endonucleolytic activity towards a thymidine glycol-containing substrate in
presence of Ku and DNA-PK is plotted. The abundance of detected cleavage products was
measured using ImageQuant 5.1 densitometry software and is reported as a function of
time. The total cleavage for thymidine glycol containing substrate was lower than
corresponding normal substrate.
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the last paired base in a duplex DNA before a 3 base 3ʹ-overhang that is amenable to cleavage by
Artemis endonuclease activity. The substrates were incubated with recombinant soluble Artemis
in presence or absence of Ku and DNA-PK for 10 – 120 min, to assess the dependence of
Artemis reaction on availability of DNA-PK component proteins. As expected, resection of the
modified and the corresponding normal substrate by Artemis was completely dependent on
availability of DNA-PK and Ku in presence of ATP (Fig. 4-17A, compare lanes 6 with 11 and
lanes 18 with 22).
For the 8-oxoG substrate, the abundance of detectable cleavage products were higher
than corresponding normal substrate, indicating stimulation of Artemis activity by the presence
of the modified base close to end termini. On closer examination, we found that there was little if
any single nucleotide trimming, with predominant removal of 2 bases from the 3ʹ-end to generate
a 12-mer, 2-nucleotide cleavage product, that reached maximum abundance at 30 min post
incubation. The abundance of this specific product was particularly enhanced 2-3 fold in the
modified substrate relative to an analogous product generated from the normal guanine
containing substrate (Fig 4-17 B), for which there was minimal overall detected trimming
activity and little trimming specificity (Fig. 4-17A, compare lanes 6-8 and 17-19). Moreover,
addition of Ku to the reaction stimulated Artemis:DNA-PK mediated endonucleolytic reaction
without altering the product distribution, in contradiction to previous results that this reaction
was independent of Ku (Ma et al. 2002) (Fig. 4-17A, compare lanes 6 with 10, and lanes 17 with
21). Though the stimulated Artemis activity was not observed for the resection of the 8-oxoG
residue itself, once the modified base was removed, the activity returned to levels comparable to
that seen with cleavage of the corresponding normal substrate (Fig 4-17A, B, C, D and E).
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Thymidine glycol, owing to its nonplanar structure, has been shown to severely block
replicative and translesional DNA polymerases (Aller et al. 2007) (Zhou et al. 2008). In contrast
to the 8-oxoG substrate that altered specificity of Artemi-mediated end trimming and stimulated
cleavage, the presence of thymidine glycol severely blocked Artemis activity (Fig. 4-18A).
Substrate incubations with Artemis, Ku and DNA-PK showed approximately 2 fold lower
cleavage activity (determined by quantification of total cleavage products by densitometry) than
the corresponding unmodified normal thymidine containing DNA, even at extended incubation
times of 2 hours (Fig 4-18B). These results suggest that Artemis 3ʹ5ʹ endonucleolytic activity
may resolve complex DNA ends with a flanking 8-oxoguanine, but not with a thymidine glycol,
which may require additional factors for processing.

4.8 Metnase endonucleolytically resects ssDNA overhangs of a duplex DNA substrate.
Metnase has been shown to possess ssDNA cleavage activity (Roman et al. 2007). To
investigate the biological relevance of this activity, plasmid-length substrates were constructed
by ligating 5ʹ-labeled 23 mer or a 17 mer oligonucleotide to a 3ʹ-resected plasmid generating 12base adenine (Long A), 6-base adenine (Short A) or 6-base thymidine (Short T), 3ʹ-overhangs
(Fig 4-19C). These substrates with varying 3ʹ-overhang length and end sequence were subjected
to Metnase reaction for various times (2 hr and 4 hr) as indicated, and then released from the
plasmid by Taq1 digestion and analyzed by 20% PAGE.
Metnase was found to cleave on both ss- and dsDNA regions of the duplex DNA
substrates, but the detected cleavage activity was preferential towards the ssDNA regions. Long
12 base 3ʹ-overhangs were efficiently trimmed to generate shorter product spectrum
predominantly corresponding to 2-8 nt 3ʹ-overhangs (23 mer gave a product distribution ranging
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Figure 4-19. Stimulation of Metnase mediated resection by increase in length of
ssDNA overhangs. All samples were treated with 50 nM of Metnase as indicated. (A) a
3ʹ-resected plasmid with an 11-base 5ʹ-overhang was prepared as described, to which
5ʹ-labeled 23-mer or 17-mer was ligated to generate 12-base or 6-base 3ʹ-overhang.
Following 2hr or 4hr Metnase treatment, the labeled substrates were digested with TaqI,
resolved by 20% PAGE, exposed 24 hrs to a phosphoimager screen and scanned on a
Typhoon scanner. The numbers indicate size of resected products. (B) Total abundance of
cleavage products is plotted as a percentage of the un-resected substrate (23-mer or 17mer band) after subtraction of the control lanes. Error bars indicate SEM for 2
independent experiments (C) Sequence of substrates is shown. Arrows indicate major
cleavage positions interpreted from gel shown in (A). The star shows the position of the
32
P label. Long A vs Short A (50 nM, 4hr, t test), p = 0.31
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Figure 4-20. Metnase 3ʹ-end cleavage specificity is altered by a change in sequence of
overhangs. (A) Substrates were treated with 50 nM Metnase for indicated time in hours.
The released 17-mer upon TaqI cleavage resolves differently on 20% PAGE due to
sequence differences. Numbers indicate size of major products. (B) Total abundance of
cleavage products in indicated lanes is plotted as a percentage of the un-resected substrate
(17-mer band) after subtraction of the control lanes. Error bars indicate SEM for 2
independent experiments (C) Partial sequence of the substrates is shown. Arrows indicate
major cleavage positions interpreted from gel shown in (A). The star shows the position
of the 32P label. Long A vs Short A (50 nM, 2hr, t test), p = 0.18. Long A vs Short A (50
nM, 4hr, t test), p = 0.20
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from 13-mer to 19-mer) (Fig. 4-19A) This product pattern also suggests that approx. 2-3
nucleotides from the 3ʹ-ends and ss/ds DNA junction are excluded as sites of cleavage by
Metnase. Though a similar product distribution was observed when the unligated 23 mer used to
construct the plasmid length duplex long A substrate was subjected to Metnase reaction, the
intensity of cleavage products was diminished indicating that Metnase nuclease activity could be
confined to ssDNA overhangs of partial duplex DNA (Fig 4-19A). Analysis of total cleavage
following Metnase nuclease reaction revealed that the long A substrate was cleaved ~2 fold more
than the short A substrate indicating that the longer 3ʹ-overhangs may be the preferred
biologically relevant substrate for Metnase (Fig 4-19B).
Metnase cleavage specificity was also altered with the change in sequence of the
3ʹ- overhangs from 6-base Adenine (Short A) to 6-base thymidine (Short T). For substrates with
6-nt adenine overhang (17-mer), 4-nt cleavage from the 3ʹ-terminal to generate a 2-base
overhang product (13-mer) was predominant, while a 6-base Thymidine 3ʹ-overhang was cleaved
to also generate a 3-nt cleavage product (14-mer) in addition to the product spectrum generated
by the Short A substrate (Fig 4-20A). A hotspot of cleavage was also interestingly generated in
the duplex DNA region of the short T substrate unlike that observed with either the short A or
the long A substrates (9-mer, 2-base 5ʹ to the blunt end). The total cleavage of the substrate by
Metnase was also higher when all 6 adenine bases were replaced by thymine (Fig 4-20B).
These results suggest that Metnase end-trimming activity depends upon both length and
sequence of the ssDNA overhang. Thus, Metnase endonuclease may resolve physiologically
relevant long ssDNA overhangs for facilitating end joining but this function is sensitive to
changes in DNA sequence.
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4.9 3ʹ-phosphoglycolate termini on longer DNA overhangs altered specificity and
stimulated Metnase-mediated cleavage.
DNA DSBs induced by radiation or some radiomimetic drugs bear 3ʹ-PG termini that may inhibit
repair by blocking polymerases and ligases. These oxidatively modified DNA ends need to be
resected before DNA repair can proceed, and several enzymes like Tdp1, Ape1 and Artemis have
been shown to process such ends in the context of NHEJ repair. Though Metnase can
endonucleolytically cleave oligonucleotides and 3ʹ-ssDNA overhangs of a duplex DNA substrate,
its activity towards modified DNA termini is unknown.
To generate substrates mimicking DSBs arising due to oxidative damage, a 3ʹ-resected
plasmid with an 11-base 5ʹ-overhang was prepared as described, to which 5ʹ-labeled oligomers of
various lengths (12, 14, 15 and 17 mer) with 3ʹ-PG termini (12-PG, 14-PG, 15-PG and 17-PG)
were ligated to give 1, 3, 4 and 6-base overhang with phosphoglycolate ends. Processing of 3ʹoverhanging termini was assessed on 20% PAGE following digestion of the treated plasmid with
AvaI or TaqI to release the labeled oligomer from the 3ʹ-end. Metnase treatment of the various
3ʹ-PG substrates revealed that it may be a candidate protein to resolve such damaged ends for
efficient repair.
When a 3ʹ-PG-terminated 1-base (12-PG) or 3-base (14-PG) overhanging substrate was
treated with increasing concentrations of Metnase, the predominant cleavage occurred in the
region of duplex DNA. Both substrates were preferentially cleaved internally from the 3ʹterminus to release a 5ʹ-labeled 9-mer as the prominent product upon Taq1 cleavage (Fig 4-21A,
lanes 7 and 8, Fig 4-21C, lanes 7 and 8). However, for the 1-base overhang 3ʹ-PG substrate,
shorter products originating from cleavage in the duplex region were also evident that were not
seen for the 3-base overhang 3ʹ-PG substrate.
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase
endonuclease activity. (A) a 12- or 15-mer 3ʹ-PG or 3ʹ-OH was ligated to the 3ʹ-resected
end of a plasmid to generate substrate with a 1-base or 4-base 3ʹ-overhang. The substrates
were treated with indicated amount of Metnase for 2 hr. The sequences for the substrates
used are shown on the top panel. The numbers (2, 3, 4, 5) indicate number of nucleotides
removed from the 3ʹ-end and are also shown on the substrate sequences on the top panel.
(B) The graph shows abundance of products resulting from cleavage of 2, 3, 4 or 5
nucleotides from the 3ʹ-end for 1-base overhang (top panel) or a 4-base overhang (bottom
panel) following 100 nM Metnase treatment. The abundance of total cleavage products
following 100 nM Metnase treatment is also shown.
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase
endonuclease activity. (C) A modified 14-mer was used to construct internally labeled
plasmid substrate with 3ʹ-PG end or an 8-oxoG positioned before a 3-base 3ʹ overhang.
The substrates were treated with the indicated concentrations of Metnase for 2 hr. (D)
The 2, 3, 4, 5 nucleotide and total cleavage products resulting from Metnase nuclease
reaction were quantified using ImageQuant 5.1. Error bars represent SEM for three
independent experiments.
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Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase
endonuclease activity. (E) A modified 17-mer was used to construct internally labeled
plasmid substrates with 3ʹ-PG end on a longer 6-base 3ʹ-overhang. The substrates were
treated with indicated concentrations of Metnase for 2 hr. (F) The 2, 3, 4, 5 nucleotide and
total cleavage products resulting from Metnase nuclease reaction were quantified using
ImageQuant 5.1. Error bars represent SEM for three independent experiments.
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G

Figure 4-21. Effect of 3ʹ-phosphoglycolate termini and substrate length on Metnase
endonuclease activity. (G) The abundance of total cleavage products following treatment
of 3ʹ-PG/3ʹ-OH substrates with varying overhang lengths as indicated is plotted after
normalization to the control lanes following quantification for the gels shown in Fig 421A,C,E. Metnase-mediated-end resection increases proportionally with the increase in
length of ssDNA overhangs.
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The corresponding 1-nucleotide overhang 3ʹ-OH substrate showed a similar but lower intensity
cleavage pattern as the PG substrate (Fig 4-21A, compare lanes 3 and 4 with lanes 7 and 8). For
the 3-base overhang unmodified substrate, the product distribution differed from that of the
corresponding PG substrate and indicated multiple cleavage products in addition to the
predominantly released 9-mer, indicating that the PG end may affect Metnase cleavage
specificity (Fig 4-21C, compare lanes 3,4 with lanes 7,8). Interestingly, when DNA substrates
with longer 3ʹ-overhangs (15-mer 4-base and 17 mer 6-base) were treated with Metnase, both
stimulation of cleavage and alteration of specificity was detected. The 4-nt overhang substrate
was cleaved by Metnase to generate a product pattern corresponding to preferred resection at the
ssDNA region (2 and 3 nucleotide from the 3ʹ-end) and also in the duplex DNA (Fig 4-21A lanes
9-16). Furthermore, a 3ʹ-PG moiety on a 4-base overhang stimulated Metnase endonucleolytic
activity for 2-5 nt resection from the 3ʹ-terminal, with an overall 2 fold greater abundance of the
total cleaved products than corresponding unmodified DNA Fig 4-21B, lower panel). With an
even longer 3ʹ-PG overhang containing substrate, Metnase cleavage specificity altered to
predominant resection of terminal 3 and 4 nucleotides, with no detectable cleavage in the duplex
region. A D483A mutation in Metnase completely abrogated Metnase cleavage activity towards
DNA ends (Fig 4-21E). The abundance of total cleavage products increased proportionally to
increase in the length of 3ʹ-overhangs, confirming our earlier finding that Metnase activity is
stimulated by longer ssDNA regions (Fig 4-21 F).
Overall, these results indicate that 3ʹ-PG modified termini can stimulate Metnase activity
and alter specificity of cleavage especially on longer 3ʹ-overhang regions, with a 4-base
overhang of a partial duplex DNA as being the minimum requirement for efficient cleavage in
ssDNA region.
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Figure 4-22. Thymidine glycol blocks Metnase-mediated end processing. An
internally labeled plasmid substrate on pUC19 backbone bearing a thymidine glyco l
residue as the last paired base before a 3-base 3ʹ-overhang and the corresponding normal
substrate were treated with Metnase (20, 50 and 100 nM) as indicated. Following
digestion of treated plasmid with BsrDI at 65ºC for 2 hrs, the released 23-mer end was
analyzed by 20% PAGE under denaturing conditions (left panel). Total abundance of all
detectable cleaved products following 100 nM Metnase treatment was quantified using
ImageQuant and results following normalization with respective untreated controls are
plotted. Error bars represent SEM for two independent experiments (right panel).
Thymidine glycol vs Normal (100 nM, t test), p = 0.16.
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4.10 Thymine glycol inhibits Metnase endonucleolytic activity.
As discussed previously, oxidative base damage is a hallmark of complex DNA DSBs
and may block NHEJ repair. These damaged bases are generally repaired by the base excision
repair mechanism, however, if the base damage arises in the context of a DSB, then it is possible
that NHEJ nucleases may recognize and resect the damaged base to facilitate completion of
repair. We have shown that Artemis activity is stimulated by the presence of 8-oxoguanine and
inhibited by thymine glycol. Since Metnase may form a part in NHEJ repair machinery, we
subjected the physiologically relevant 8-oxoguanine and thymidine glycol substrates (described
previously) to 20, 50 and 100 nM Metnase. Metnase activity was not stimulated and its cleavage
pattern remained unaffected by the presence of oxidized guanine at the ssDNA/dsDNA border
before a 3-base 3ʹ-overhang, which was cleaved with equal efficiency as a normal guanine
substrate (Fig 4-21C, compare lanes 3, 4 with lanes 11,12, Fig 4-21D). However, a nonplanar
thymidine glycol blocked Metnase mediated resection of the ssDNA overhangs (Fig 4-22).
Interestingly, no cleavage in the duplex DNA region was observed for the thymidine glycol
substrate, suggesting that Metnase may load from the DNA ends and that once it encounters the
modified residue it may be blocked from cleaving the substrate further. Since an 8-oxoguanine
residue failed to alter, and thymidine glycol inhibited Metnase nuclease activity, complex DNA
DSBs may not be biologically relevant susbtrates for Metnase-mediated resection and require
other NHEJ factors like Artemis for resolution.

4.11 Metnase endonucleolytic activity is independent of Ku and DNA-PK.
Recruitment of Ku heterodimers and DNA-PK to the DSB ends is considered to be
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Figure 4-23. Metnase endonuclease activity is independent of DNA-PK and Ku
availability. (A) The internally labeled long A substrate generated by ligating the 23 mer
oligonucleotide to 3ʹ-resected plasmid was incubated for 20 min with DNA-PK (65 nM)
and Ku (25 nM) followed by S1-Nuclease ( 0.3U, 25 ºC, 5 min). S1-nuclease reactions
were performed in the absence of ATP. The same substrate was incubated with Metnase
(50 nM), DNA-PK (65 nM) and Ku (25 nM) for 4 hrs at 37 ºC. S1-nulcease was chosen
for footprinting because of its specificity towards ssDNA overhangs.
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B

Figure 4-23. Metnase endonuclease activity is independent of DNA-PK and Ku
availability. (B) The footprint experiment shown in (A) is quantified. Cleavage of
indicated nucleotides by Metnase or S1-Nuclease in presence of Ku and DNA-PK
(lanes 1 and 4) is plotted as a percentage relative to the cleavage in presence of
Metnase and S1-nuclease alone (lanes 3 and 6). Error bars indicate SEM for two
independent experiments.
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essential for repair by NHEJ pathway. Ku 70/80 forms a bridge between DNA ends helping
alignment and also facilitates DNA-PK binding to the DNA ends. Once bound, DNA-PK
acquires a S/T kinase activity and both DNA-PK autophosphorylation and DNA-PK-mediated
phosphorylation of NHEJ factors has been shown to affect repair by NHEJ. Moreover, Ku and
DNA-PK are essential for stimulation of Artemis endonucleolytic activity (Yannone et al. 2008).
Thus, to determine whether NHEJ proteins Ku and DNA-PK stimulate or otherwise affect
Metnase cleavage function on long ssDNA overhangs, a 12-base 3ʹ-overhang plasmid substrate
was incubated with Metnase (50 nM) both in the presence and in the absence of Ku (25 nM) and
DNA-PK (65 nM). Ku alone did not alter Metnase endonuclease activity towards DNA ends,
however Ku along with DNA-PK was found to partially protect the ssDNA overhang from
Metnase mediated resection (Fig 4-23A). Since the protection was not complete, we performed
an S1 nuclease footprint assay (instead of DNase1, since S1 nuclease preferentially cleaves
ssDNA) to determine the extent of Ku and DNA-PK binding to the long 3ʹ-overhang region.
Substrate incubation with Ku and DNA-PK prior to S1 nuclease treatment, resulted in approx. 50%
protection of the ssDNA overhang which interestingly was more than the protection afforded
against cleavage by Metnase (Fig 4-23B). Ku alone did not affect S-1 nuclease activity (Fig. 423A) suggesting that Ku when not bound to DNA-PK may slide to the interior of the duplex
DNA region, thus exposing the ssDNA region for Metnase mediated resection (hence no
differences from Metnase reaction alone). As indicated by S1-nuclease footprint assay, in
presence of DNA-PK, more protein may be retained on DNA ends as a complex, thus protecting
the ends from Metnase activity.
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V. DISCUSSION
Direct rejoining of DSBs generated by ionizing radiation or certain radiomimetic
chemotherapeutics is precluded by the presence of fragmented sugars and damaged or missing
nucleotide bases near DNA-termini. Free radical-mediated oxidation at the C-4ʹ position of the
deoxyribose in DNA results in sugar fragmentation and strand cleavage, releasing a base
propenal and leaving a two carbon fragment –PO4CH2COOH (PG) linked to 3ʹ-end of the break
(Chen et al. 2007). The three DNA-damaging agents used in this thesis work, i.e., radiation, NCS
and bleomycin, generate different types of 3′-PG-terminated DNA DSBs. Bleomycin treatment
gives rise to DSBs having either blunt ends or single-base 5′ overhangs, with 5′-phosphate and
3′-PG termini at both ends of the break. NCS-induced DSBs have at one end a 5′-phosphate and
a 3′-phosphate on a 2-base 3′-overhang. The opposite end has a 5′-aldehyde and either a 3′-PG
(~20%) or a 3′-phosphate (~80%) on a one-base 3′-overhang (Povirk 1996, Dedon, Goldberg
1990). About half of radiation-induced strand breaks bear 3ʹ-PG termini in different contexts and
many of these are presumably on 3ʹ-overhangs of DSBs. These end groups can block DNA
polymerases and DNA-ligases to inhibit repair (Noguti, Kada 1975) and unrepaired DSBs can
lead to mutations and cell death. Thus, in the repair of such blocked DNA lesions, a step of
paramount importance is removal of the 3ʹ-PG termini, which must precede gap filling and religation of the DSB. Several enzymes have been biochemically shown to resolve 3ʹ-PG ends, on
DSBs.

Apurinic/apyrimidinic

endonuclease1
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(APE1)

can

remove

PGs

on blunt and 3ʹ-recessed ends, however PGs on short 3ʹ-overhangs are not removed by APE1
(Suh, Wilson III & Povirk 1997). TDP1 can also process 3ʹ-PG termini but has substrate
specificity opposite to that of APE1. Though it can resect 3ʹ-PG ends on overhangs, the
processing of PG termini by TDP1 is inefficient compared to a phosphotyrosyl substrate.
Moreover, it leaves a 3ʹ-phosphate end that needs to be removed by PNKP so that the DNA end
can be ligated.
Artemis was originally identified as the gene localized in chromosome 10 that codes for a
V(D)J recombination/DNA repair factor belonging to metallo-β-lactamase family of proteins.
Mutations in Artemis gene result in RS-SCID due to a defect in the hairpin opening step of
V(D)J recombination leading to T-B-NK+ phenotype. Artemis has also been implicated in
resolving PG ends on short 3ʹ-overhangs as well as blunt DNA ends, but slowly. Artemis can
also interact with and be stimulated by other NHEJ factors like DNA-PK and Ku. Experiments
using defined substrates and purified enzymes have shown that in the presence of DNA-PK,
Artemis gains an endonucleolytic activity toward DNA ends that is capable of resolving DSBs
bearing terminal blocking groups such as 3ʹ-PGs (Povirk et al. 2007). Artemis deficiency has
pleiotropic effects in human cells following exposure to DNA damaging agents, including
defects in regulation of cell cycle checkpoints (Wang et al. 2009, Geng et al. 2007) and in
apoptotic DNA fragmentation (Britton et al. 2009). Other studies suggest that Artemis is epistatic
with ATM in promoting radiosurvival and DSB repair, even in growth-arrested cells that should
not be subject to cell cycle effects (Riballo et al. 2004). This thesis work investigates whether the
endonucleolytic activity of Artemis is its biologically relevant function for promoting cell
survival following exposure to ionizing radiation and radiomimetic drugs. Since the majority of
induced DSBs are repaired even in Artemis-deficient cells, there must be other nucleases or
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phosphodiesterases that can resolve blocked ends in different contexts. The biochemical role of
Metnase, a candidate nuclease for processing of blocked DNA DSBs during NHEJ, has also been
studied as part of this work.
To investigate whether the endonucleolytic activity of Artemis functions in
chemo/radioresistance, patient-derived CJ179 cells defective for Artemis were complemented
with lentiviral vectors expressing wild-type or D165N Artemis. The D165N mutation eliminates
Artemis-mediated endonucleolytic processing of 3ʹ-PG DSB ends in vitro (Yannone et al. 2008,
Povirk et al. 2007). To establish the role of Artemis nuclease activity in DNA repair and cellular
survival after DNA damage, clonogenic and DSB-repair assays were carried out with these cells,
following treatment with radiation or radiomimetic drugs. Earlier studies (Riballo et al. 2004,
Beucher et al. 2009) investigating complementation of Artemis defect by exogenous protein
expression were carried out with transiently expressing cell lines due to difficulties in expressing
Artemis in cells (Beucher et al. 2009). In contrast to these studies, our collaborator, Dr. Steven M.
Yannone was successful in stably complementing Artemis-deficient fibroblasts with WT or
D165N mutant Artemis, allowing us to explore the effect of such expression on the critical
endpoint of survival following radiation or genotoxic chemical treatment. Survival assays with
stably complemented cell lines show that only WT endonuclease-proficient Artemis is able to
restore radio/chemoresistance and that an endonuclease-deficient Artemis fails to do so (Fig. 4-5).
These data indicate that a lack of endonuclease activity and thus of end-processing is the
principal cause of radio/chemosensitivity of Artemis-deficient fibroblasts. Though an effect of
D165N mutation on recruitment to damaged DNA ends cannot be completely ruled out, the
mutant protein has been shown to be phosphorylated by DNA-PK and retains its 5ʹ3ʹ
exonuclease activity, suggesting that the mutant protein may properly attain tertiary structure to
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bind DNA ends and retain functionality. Recently, it was shown that most (but not all) of the
exonuclease activity can be separated from the endonuclease activity. Recombinant His 6-tagged
Artemis expressed in a Baculovirus insect cell expression system and purified on a Ni-agarose
affinity column still retained both activities. The two activities were partially fractionated on an
ion exchange hydroxyapatite column (Pawelczak, Turchi 2010). However, other studies showed
that extensively purified Artemis protein retained exonuclease activity (Gu et al. 2010), and that
antibodies raised against Artemis protein gel-purified from Escherichia coli inactivate the
exonuclease, suggesting that this exonuclease activity is intrinsic (Yannone et al. 2008).
Artemis has also been speculated to have a cell cycle regulatory role following DNA
damage. It has been shown to affect cell cycle recovery from G2/M and S-phase cell cycle
checkpoints. The finding that endonuclease-deficient Artemis, even when overexpressed, has no
effect at all on chemo/radiosurvival (Fig.4-5), combined with evidence that Artemis-deficient
fibroblasts retain functional G1 and G2 checkpoints (Wang et al. 2005, Krempler et al. 2007),
would also appear to exclude a checkpoint defect as a major contributor to the
chemo/radiosensitivity of Artemis-deficient fibroblasts. Although checkpoint deficiencies have
been reported for tumor cells in which Artemis expression has been knocked down with siRNA
(Wang et al. 2009, Geng et al. 2007), there is no evidence that these deficiencies account for
radiosensitivity.
PFGE as well as focus-formation assays in noncycling contact-arrested fibroblasts
(Figure 4-6, 4-7, 4-9) show that wild-type but not endonuclease-deficient Artemis completely
restores DSB-repair proficiency, in agreement with recent observations in G2 cells where
Artemis was expressed transiently (Beucher et al. 2009). Previous studies have also suggested
that Artemis deficient cells fail to rejoin a subset of DNA DSBs, but the exact nature of these
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breaks remains undefined. Since the endonucleolytic activities of Artemis/DNA-PK do not
require a specific structure at either the 5ʹ or the 3ʹ ends and can bypass terminal moieties
(Yannone et al. 2008), these activities could serve to remove chemically modified termini such
as 3ʹ-PGs and 5ʹ-aldehydes that are generated following treatment with radiation, bleomycin or
NCS. It is highly unlikely that the exonucleolytic activity of Artemis plays a role in resolving
such blocked 3ʹ-ends since it acts on 5ʹ-termini and requires a 5ʹ-phosphate. Artemis
exonucleolytic activity is also suppressed by the presence of DNA-PK, which is expected to be
bound to DNA-ends during DSB repair in G1. Taken together, these results strongly suggest that
the primary function of Artemis in DSB repair is the endonucleolytic processing of DNA ends.
However, in both Artemis deficient and Artemis mutant cell lines, the majority of
radiation and NCS-induced DSBs (~80%) are repaired within 2 hrs, raising the question as to
why only a subset of DNA DSBs require endonucleolytic trimming by Artemis for repair, while
the majority do not. At least for NCS-induced DSBs, the repair-resistant, Artemis-requiring
fraction cannot be a subset of complex DSBs with accompanying base damage, as neither NCS
nor bleomycin produces such lesions (Povirk 1996, Dedon, Goldberg 1990). It is also unlikely
that there is a one-to-one correspondence between 3ʹ-PG DSBs and DSBs requiring Artemis for
repair, as in that case Artemis-deficient cells should be much more sensitive to bleomycin, which
forms DSBs that have almost exclusively 3ʹ-PG termini at both ends, than to any of the other
agents. Another possibility is that the DSBs that absolutely require Artemis may be those arising
in heterochromatin. Heterochromatic DSBs are thought to be particularly difficult to repair
because the condensed DNA may preclude certain factors of the DNA repair machinery access to
DNA ends. Moreover, the heterochromatic DNA constitutes about 20% of the genome which
correlates with the amount of DSBs that are repaired with slow repair kinetics and are dependent
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on ATM for repair (~20%). ATM has been shown to promote local decondensation of
heterochromatin by several groups (White et al. 2012, Goodarzi et al. 2008, Fernandez-Capetillo,
Nussenzweig 2008) and since Artemis is epistatic with ATM in DSB repair (Fernandez-Capetillo,
Nussenzweig 2008), it is by inference thought to play a role in repair of heterochromatic DSBs.
If the unrepaired DSBs are those in heterochromatin, as has been proposed for DSBs that require
ATM for repair, then there must be alternative enzyme(s) [e.g. TDP1; (Inamdar et al. 2002, Zhou
et al. 2009)] that are biochemically competent to resolve the damaged ends, but are specifically
excluded from heterochromatic DSBs. Alternatively, the repair focus-associated protein
complexes that are recruited to unrepaired DSBs may effectively shield the breaks from most
enzymatic processing, so that any breaks which fail to repair within 1–2 h (including those in
heterochromatin) can only be processed by Artemis, due to its close association with DNA-PK
(Ma et al. 2002, Goodarzi et al. 2006). A recent study of repair joints from a site-specific HO
endonuclease-induced DSB in mouse mammary cells has raised yet another alternative: that in
heterochromatin Artemis may excise a whole DSB-containing nucleosome, exposing
internucleosomal DNA at both ends of the break that can then be more easily joined (KanikarlaMarie, Ronald & De Benedetti 2011). A final possibility is that a fraction of the initial DSBs
may be processed into derivative structures that only Artemis can resolve, for example, hairpins
resulting from single-strand resection at inverted repeat sequences, as suggested previously
(Povirk et al. 2007).
A time-dependent increase in the size of both γ-H2AX and 53BP1 foci was observed 618 hr post-irradiation for Artemis deficient and D165N Artemis mutant cell lines. A similar
increase in size of residual foci has been previously reported for cells exposed to high linear
energy transfer radiation (Ibañez et al. 2009), which induces complex DSBs that are relatively
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resistant to repair and persist for longer times. One study that followed foci along α-particle
tracks in three dimensions, showed that these foci often coalesce into a few larger foci (Aten et al.
2004). Exposure to high salt immediately after γ-irradiation can also promote increased focus
size, an effect attributed to inhibition of repair, due to chromatin compaction (Reitsema et al.
2004). Thus, in several contexts, persistent unrejoined DSBs appear to promote further H2AX
phosphorylation and aggregation of repair factors, suggesting continued ATM/DNA-PK
activation (Bakkenist, Kastan 2003) and a gradual spreading of decondensation over larger areas
of chromatin (Kinner et al. 2008). The determinants that control H2AX distributions are still
unknown, but it is believed to be bidirectional and may not be entirely uniform on both sides of
the break (Iacovoni et al. 2010). Thus, increase in focus size indicates persistent DSBs in cells
deficient in functional Artemis protein, suggesting that a subset of DNA DSBs absolutely require
processing by Artemis for their resolution.
The persistent DNA DSBs represented by large γ-H2AX foci were further analyzed by
co-immunostaining in an effort to identify other NHEJ factors that may have accumulated at
these loci and may presumably play a role in the Artemis-dependent NHEJ pathway for repair of
breaks that show slow repair kinetics. Both 53BP1 and Mre11 were found to co-localize with
regions of phosphorylated γ-H2AX (Fig. 4-8, 4-13). Recently 53BP1 was shown to be an
essential factor for promoting heterochromatic DSB repair. ATM promotes DSB repair in
heterochromatin by phosphorylating KAP1 (KRAB associated protein 1). Cells that did not form
53BP1 foci (human RIDDLE syndrome cells) also failed to form p-KAP1 foci (Noon et al. 2010).
Thus, 53BP1 may also be essential for Artemis-dependent heterochromatic DSB repair and for
amplification of Mre11 accumulation at late repairing foci (Figure 4-13). MRN complex plays an
important function in facilitating activation of ATM kinase, which also requires direct interaction
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between BRCT domains of 53BP1 and Mre11 (Lee et al. 2010). Mre11 and associated proteins
have a 5ʹ3ʹ processing activity that may convert 3ʹ-PG containing blunt ends or short 3ʹoverhangs to longer 3ʹ-overhangs that is a more favorable Artemis substrate. The simultaneous
increase in size of Mre11 foci along with γ-H2AX and 53BP1 suggests that Mre11 is also
epistatic with Artemis for repair of DSBs.
Moreover, these persistent breaks were seen to juxtapose with PML-NBs (Figure 4-14).
PML is a known tumor suppressor (Lallemand-Breitenbach, de Thé 2010, Yang et al. 2002) and
is a key constituent of PML-NBs along with Daxx, SP100 and CBP. PML protein itself is
thought to be the main organizer of these diverse groups of proteins whose commonly identified
feature is their ability to be sumoylated. SUMO (Small Ubiquitin like Modifier) is a posttranslational modification that is thought to be the essential for PML-NB assembly. PML protein
itself forms the outer shell of the NBs and the other constituent proteins are usually in the core.
PML-NBs are usually present in the interchromosomal space under normal conditions
(Lallemand-Breitenbach, de Thé 2010, Guiochon-Mantel et al. 1995).
PML-/- cells and mice have been shown to be resistant to lethal effects of γ-radiation.
Cds1/Chk2-mediated phosphorylation of PML triggers apoptosis (Yang et al. 2002) probably
through recruitment of Daxx to nuclear bodies (Zhong et al. 2000). PML is phosphorylated by
several DNA damage activated kinases such as ATM and ATR (Lallemand-Breitenbach, de Thé
2010) and associates with hMre11 and p53 at 12–24 hr following irradiation (Carbone et al.
2002). PML-NBs have recently been shown to support DNA DSB repair by homologous
recombination. PML knockdown by siRNA resulted in a defect in PML-NB formation that
resulted in 20 fold decrease in HRR. It is speculated that PML-NBs may not affect the early steps
of HRR like DSB recognition but may inhibit later steps of DNA repair (Yeung et al. 2011). Our
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results that PML NBs partially juxtapose with late repair foci in Artemis-deficient cells suggest
that these foci represent highly persistent unrepaired DSBs that continue to recruit additional
DNA-repair machinery for their resolution. Repair-focus expansion may also reflect a search for
additional DNA end(s) that can be resolved into a ligatable substrate. At least for UV-induced
DNA damage, the nuclear bodies were shown to recruit single-stranded DNA molecules in
response to the damage (Boe et al. 2006). Moreover, confocal real-time imaging of YFP-tagged
PML did not show either splitting of PML-NBs as reported by other groups (Carbone et al. 2002)
or formation of de-novo NBs (Boe et al. 2006). These results suggest that PML-NBs may be
permanent nuclear structures and the ssDNA focus formation was hypothesized to form within
the pre-existing PML-NBs. Thus PML-NBs may have an intrinsic ability to recruit damaged
DNA and organize repair and processing events to resolve the damage. Partial co-localization of
PML NBs in our results (Fig. 4-14) at later time points and in the absence of endonucleolytically
active Artemis suggests that the damaged chromosomal DNA may be subjected to extensive
exonucleolytic resection on one strand leading to generation of areas of ssDNA that may be
sequestered by the PML-NBs.
However, the involvement of PML-NBs in NHEJ repair is still under dispute (Yeung et al.
2011), hence another possibility could be that these recalcitrant DSBs that are not repaired by
NHEJ machinery due to lack of functional Artemis at DNA ends may be directed towards HRR
at later time points, and the juxtapositioning of PML-NBs at unresolved DNA ends may signify
this change. Recently, a mutation in the BRCT domain (M1775R) of BRCA1, an essential HRR
gene, was also found to induce unusual thread-like PML-NBs and clustered RPA foci rather than
the expected partially colocalized RPA:PML foci seen with WT BRCA1 (Dever et al. 2011).
Hence, PML-NBs may also be sites for processing of HRR complexes. Moreover, if the repair
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efforts by the cell fail, then the constituent proapoptotic proteins of PML bodies may drive cells
toward cell-death.
Our results also show that an overexpression of wild-type Artemis in normal cells adds to
the survival advantage of these cells (Figure 4-16), however, no effects on repair (PFGE or foci)
were detected (Fig. 4-15). Since no added repair advantage was detected in these cells by PFGE
or focus formation assays, it is possible that in presence of excess of Artemis, some breaks which
can be repaired by multiple redundant pathways may be channeled through an Artemisdependent pathway. This NHEJ sub-pathway may be less error-prone than the alternative(s), and
the resulting higher fidelity of repair might lead to increased survival without necessarily
affecting measurements of DSB rejoining. However, once a critical level of Artemis expression
is reached in cells, additional protein does not confer any increased survival advantage (Fig 4-11).
This result suggests that in the Artemis transgene-expressing cells, the concentration of Artemis
at DSBs is no longer a limiting factor in repair. Though it is unknown how may molecules of
Artemis may recruit to DNA ends and whether there is a one-to-one correlation between Artemis
and DNA-PK required to process a given DSB in cell, it appears that low levels of Artemis
expression are sufficient to resolve even large amounts of breaks with modified ends such as
those produced in our PFGE experiments. This may also indicate that the interaction of Artemis
with DNA ends is dynamic. Once a given DSB is processed for gap filling and re-ligation,
Artemis may leave the DNA ends and recruit onto another terminally blocked DSB singly or in
complex with DNA-PK to process it. Thus, low amounts of the protein are all that is required by
the cells to resolve complex DSBs.
Conversely, overexpression of D165N mutant Artemis in normal cells made them slightly
repair-deficient as judged by PFGE (Figure 4-15B), suggesting that the mutant Artemis can
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effectively compete with endogenous protein for DNA binding. The defect in repair appears to
be expressed only when the repair system is saturated by very high levels of DNA damage.
Although there was a slight trend toward greater radiosensitivity when very high levels of mutant
Artemis were expressed in normal cells, it was not statistically significant (Figure 4-11A).
Nevertheless, the dominant-negative effect on repair as well as the increase in radioresistance
with overexpression of Artemis is most consistent with Artemis functioning directly in the repair
process.
However, repair of most DSBs do not require the presence of a functional Artemis at
DNA ends, and there is no direct correlation between sensitivity in Artemis-deficient cells and
amount of DSBs induced with 3ʹ-PG ends, because Artemis-deficient cells are not dramatically
more sensitive to bleomycin (a drug that induces DSBs bearing 3ʹ-PGs at most DNA ends),
suggesting that there are other factors that can resolve DSBs with modified 3ʹ-PG end. Metnase
is one such recently discovered enzyme that may play a role in repairing such damage.
Metnase was discovered as a SET and transposase fusion protein that owing to its dual
histone methylase and nuclease activities, was implicated in DNA repair (Lee et al. 2005a). Later
it was found to form foci at DSBs along with other NHEJ repair factors like Nbs1, which forms a
part of MRN complex. Metnase recruitment to the DSB sites requires its physical interaction
with hPso4 (Beck et al. 2008) and both SET and transposase domains have been shown to be
necessary for stimulation of NHEJ repair (Lee et al. 2005a). Metnase-mediated dimethylation of
H3K36 at DSB sites promotes association of NBS1 and Ku to DNA (Fnu et al. 2011). At the
same time experiments with oligonucleotide substrates have shown Metnase to possess a DNA
cleavage activity; however its role in processing damaged DNA ends remains to be investigated.
In this thesis we have also sought to clarify the role of Metnase endonuclease activity, in vitro,
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on physiologically relevant DNA substrates with modified 3ʹ-PG ends or nucleobase damage
such as those generated following exposure to ionizing radiation or radiomimetic agents.
When longer (5.5kb) internally labeled plasmid substrates were treated with soluble flagtagged Metnase, additional processing activities not seen in earlier studies with oligonucleotides
were revealed. Metnase showed prominent cleavage at the ssDNA regions of a duplex substrate
and the intensity of cleavage increased ~2 fold with doubling of overhang length on 3ʹ-ends (Fig.
4-19). This suggests that longer 3ʹ-overhangs may be ideal Metnase substrates in vivo. Moreover,
an alteration in cleavage specificity was observed with change in overhang sequence from 6-base
adenine (short A substrate) to 6-base thymidine (short T substrate) (Fig. 4-20). In case of the
short T substrate, Metnase cleaved with higher intensity one base closer to the 3ʹ-terminus than
the short A substrate and also generated a hot-spot of cleavage at the double-stranded region of
DNA. Moreover in all cases (Fig 4-19, 4-20), 2-3 nucleotides from the extreme end were
excluded from Metnase-mediated cleavage. If Metnase loads onto

DNA overhangs from

extreme ends then these discrepancies could be explained by differences in positioning of the
Metnase active site (D483, D575 and N610) over different substrates (Goodwin et al. 2010).
Based on crystal structure, Metnase was also proposed to act on DNA ends as a dimer (Goodwin
et al. 2010) and the interaction energies of the dimer could be different for purines than
pyrimidines. This along with deoxyribose base-stacking differences could result in more Metnase
binding to dsDNA region than ssDNA overhang composed of thymidines and hence the cleavage
difference (Goodwin et al. 2010, Kool 2001). However, the effect of base stacking differences
and active site interactions has been more extensively studied for DNA replication than DNA
cleavage.
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When the 3ʹ-OH was replaced by 3ʹ-PG (deoxyribose C-4ʹ oxidation product), the cleavage was
still dependent upon overhang length and in some cases presence of the modified end itself (Fig.
4-21A-G). For 3ʹ-blocking PG moieties on short 3ʹ-overhangs closer to duplex DNA region (≤ 3
bases) the predominant resection was in the dsDNA region compared to a 3ʹ-OH substrate that
was cleaved to generate a product pattern consistent with cleavage in both ssDNA and dsDNA
regions. For 3ʹ-PG moieties on 3ʹ-overhangs ≥ 4-base, resection was predominantly in the
ssDNA region. A 3ʹ-PG-containing 4-base overhang was cleaved with greater intensity than a
corresponding 3ʹ-OH containing substrate. Metnase cleaved only on the ssDNA region of a 6base overhang with 3ʹ-PG ends. These results may suggest that a minimum of 4-base overhang
region may be required to load Metnase to DNA ends. Moreover, an oxidatively modified DNA
end like the 3ʹ-PG moiety stimulates Metnase mediated resection and alters specificity,
indicating that these damaged ends may be physiologically relevant substrates for Metnase
processing following radiation or radiomimetic drug exposure. Metnase-mediated resection of 3ʹPG ends increased by more than 5 fold with increase in overhang length from 1-base to 6-base
(Fig. 4-21G). Long 3ʹ-overhangs with blocked termini are especially difficult to repair and can
preclude NHEJ unless resolved. Artemis has been shown to trim such longer overhangs into
ligatable ends, however most DNA DSBs do not require Artemis for repair. Such breaks may be
amenable to resection by Metnase before gap filling and ligation in an alternative NHEJ pathway
independent of Artemis. Alternatively, the longer 3ʹ-overhangs may be trimmed to 3-4 bases by
Metnase before further processing by Artemis:DNA-PK complex.
Most of the radiation-induced DNA damage sites rarely consist only of DSBs with 3ʹ-PG
ends, and are often accompanied with base damage in close proximity to the DSB with modified
termini (Asaithamby, Chen 2011). More commonly, damaged nucleobases are resolved by the
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base excision repair pathway, however if the nucleobase damage is in the vicinity of a break, it is
more likely to be removed by NHEJ endonucleases (Dobbs et al. 2008). Since such breaks are
critical determinants of cell survival, two different plasmid length substrates were constructed
with either an 8-oxoguanine or a thymidine glycol residue positioned 5ʹ to a 3-base 3ʹ-overhang.
Neither stimulation nor alteration of Metnase activity was observed for the 8-oxoguanine
substrate which showed comparable product pattern as a normal guanine containing DNA (Fig.
4-21C, D). Interestingly, the same substrate stimulated Artemis-mediated resection of 2 terminal
nucleotides from the 3ʹ-end but required the presence of both Ku and DNA-PK for maximal
endonuclease activity (Fig. 4-17). Since there was no increased Artemis activity for removal of
the 8-oxoguanine residue itself, Artemis mediated processing may precede 8-oxoguanine
removal from DNA ends by other repair factors, or the lesion itself may be bypassed by the
repair machinery.

Conversely, thymidine glycol severely blocked both Metnase and

Artemis:DNA-PK:Ku endonuclease activity (Fig. 4-18 and Fig. 4-22). The normal thymidinecontaining substrate showed a product distribution indicating endonucleolytic nucleotide
removal from the DNA ends, while for the thymidine glycol substrate there was a substantial
decrease in resection. Since thymidine glycol is non-planar, it may offer a more severe block
than the 8-oxoguanine residue (Zhou et al. 2008) and thus require other NHEJ factors for
resolution.
Ku and DNA-PK are considered to be the first proteins that are recruited to DSBs in the
canonical NHEJ pathway; hence we investigated whether Metnase nuclease activity is affected
by the presence of these proteins. On a 12-base 3ʹ-overhang, Metnase activity was unaffected by
Ku alone but was reduced to ~75-80% when DNA-PK was added to the reaction. Though,
DNase footprint assays revealed that Ku:DNA-PK holoenzyme can occupy 30 bp from the end
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of dsDNA (Povirk & Valerie 2003), the affinity of this enzyme for binding to long ssDNA
overhangs is unknown. Our S1-Nuclease footprint analysis revealed partial protection of DNA
ends by the presence of Ku:DNA-PK holoenzyme, while Ku alone had no protective effect (Fig.
4-23). This suggests that Ku when present alone may slide to the interior of the break, and is
partially retained at the ends when present in a complex with DNA-PK. Thus, unlike Artemis,
Metnase activity was not stimulated by DNA-PK and Ku, however the protection of the ssDNA
overhang towards Metnase-mediated resection was lower when compared to that of S1-nuclease.
Thus Metnase may be involved in alternative Ku:DNA-PK independent backup NHEJ pathways
for repair of DNA DSBs (Wang et al. 2003). Metnase-mediated end processing may precede Ku
and DNA-PK recruitment at DNA DSBs. Once Ku and DNA-PK are recruited to DNA ends,
further processing may occur in an Artemis-dependent pathway.
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VI. CONCLUDING HYPOTHESIS AND FUTURE PERSPECTIVES

Considering the known literature and our own results, it is also tempting to speculate on a
model NHEJ repair mechanism involving processing of the ends by Metnase and Artemis.
Following induction of blocked DNA DSBs by ionizing radiation or radiomimetics, Metnase
may be recruited to the DNA damage sites in presence of hPso4 (Beck et al. 2008). Damageinduced Chk1-mediated phosphorylation at S495 residue has been shown to aid in recruitment of
the Metnase to DNA (Hromas et al. 2012). Our results show that Metnase nuclease domain
mediated end-processing can resect both 3ʹ-hydroxyl and 3ʹ-PG containing DNA ends (Fig 4-19
4-20, 4-21). Phosphoglycolate moieties on long 3ʹ-overhangs are particularly favorable Metnase
substrates in vitro. If the generated DNA ends are compatible, then further end-processing may
not be necessary and the re-joining can occur by the alternate NHEJ pathway. Moreover,
Metnase SET domain mediated dimethylation close to the damage site has been shown to
enhance association of Ku 70/80 heterodimer and MRN complex to DNA ends (Fnu et al. 2011).
Mis-matched DNA ends require XRCC4 and XLF recruitment for alignment followed by gap
filling by DNA polymerases λ and μ and ligation in presence of DNA ligase IV for re-joining.
Experiments involving incubation of substrates with Metnase in presence of NHEJ factors Ku
and DNA-PK suggest that although Metnase can resect ssDNA overhangs in the presence of
these proteins at DNA ends, maximal resection occurs when the overhangs are not protected (Fig
4-23).

Thus,

Metnase

could

be

an early-response
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Figure 6-1. Proposed model of Metnase and Artemis dependent NHEJ pathway.
DNA DSBs originating from radiation exposure presumably bear 3ʹ-PG blocked 3ʹoverhangs. DNA damage induced Chk1 mediated phosphorylation of Metnase at S495
can facilitate Metnase:hPso4 complex recruitment to DNA ends. If Metnase can resolve
these modified DNA termini into compatible ligatable ends that do not require further
processing, they can be repaired through Alternate-NHEJ pathway. Metnase mediated
dimethylation at H3K36 can facilitate recruitment of Ku:DNA-PK and MRN complex
followed by repair via canonical NHEJ pathway. However, DSBs originating in the
heterochromatin or complex DSBs associated with nucleobase damage require Artemismediated endonucleolytic processing for re-joining and show slow overall repair kinetics.
The slow-repairing subset of DSBs form large γ-H2AX foci, especially if functional
Artemis is not present and juxtapose with PML-NBs at later time points. If the DSBs still
remain unrepaired then the pro-apoptotic machinery in PML-NBs may drive cells towards
cell death.
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of the Metnase-mediated processing possibly occuring before recruitment of Ku and DNA-PK to
DNA-ends and on longer overhangs that may not be efficiently bound by these proteins. The
longer overhangs may be trimmed to shorter more easily ligatable ends facilitating further
processing through the canonical end-joining pathway.
While this work has shown that Metnase endonuclease activity can trim blocked 3ʹ-PG
DSB ends, whether this activity can facilitate end joining needs to be investigated. A D483
residue in the DDE motif of the protein is known to be essential for the Metnase endonuclease
activity and a D483A mutant Metnase has no detectable cleavage function (Fig. 4-21E). Recently
solved crystal structure of Metnase also suggests that dimerization of the protein may be required
for optimal DNA binding and cleavage activities (Goodwin et al. 2010). A phenylalanine 460
residue was considered essential for dimerization and the F460K mutation was shown to
preclude formation of the Metnase dimer and inhibited ssDNA cleavage activity using oligomers.
In vitro end-joining assays with cell extracts complemented with either D483A (endonuclease
deficient) or F460K (dimerization deficient) mutant Metnase and WT Metnase may further
clarify if cleavage of blocked DNA ends by Metnase can facilitate NHEJ. Though the present
evidence suggests that a Metnase monomer may not be able to bind DNA and stimulate endjoining, addition of Metnase interacting proteins like hPso4 to the end-joining reactions may
demonstrate if the monomeric protein can be recruited to DNA ends and retain activity. Further,
generation of D483A mutant (endonuclease deficient) and WT Metnase expressing cell lines
may clarify whether the endonuclease activity of the protein is an important determinant of cell
survival following genotoxic insult. However, due to the unavailability of Metnase null or
knockout cell lines, these experiments may be inconclusive. Moreover, DSBs associated with
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nucleobase damage are not ideal Metnase substrates (Fig. 4-21C and 4-22) suggesting that endprocessing by other NHEJ factors may be required to resolve complex DNA DSBs.
Results in this thesis also suggest that a fraction of DSBs with chemically modified
termini require Artemis endonuclease activity for repair in G1 (Fig 4-7). This subset of breaks
could either be DSBs arising in the heterochromatin that is exclusively accessible to Artemis or
could be regions of complex DNA damage that may indispensably require Artemis for resolution
(Riballo et al. 2004, Beucher et al. 2009, Goodarzi et al. 2008). If the 10-20% DSBs that fail to
rejoin are heterochromatic then euchromatinization of DNA using a histone deacetylase inhibitor
should reduce heterochromatic DNA in cells and lead to efficient repair even in the absence of
Artemis. Double-immunostaining experiments using anti-Tri-Me K9 Histone H3 and γ-H2AX
antibody could reveal the percentage of residual foci co-localizing to the regions of
heterochromatic DNA. Alternatively, the residual breaks could be separated using pulsed field
gel electrophoresis, Southern blotted and probed with α-satellite DNA probe to identify the
fraction of heterochromatic DNA remaining un-rejoined. If the subset of breaks that are
unrepaired at later times are clustered DNA damage with 3ʹ-PGs and 8-oxoguanine in close
proximity, as is suggested in this dissertation work, then treating Artemis deficient cells with I 125,
an auger electron emitter that produces such breaks should increase the number of residual foci.
In any case, evidence from both in vivo and in vitro work performed here indicate that this
Artemis dependent pathway for resection of damaged DNA also requires Ku and DNA-PK with
recruitment of MRN complex, 53BP1 and at later time points PML-NBs. The complete failure of
endonuclease-deficient Artemis to improve survival suggests that lack of end-processing by this
endonuclease can fully account for the chemo/radiosensitivity conferred by Artemis deficiency.
In case the DSBs are not repaired for extended times then constituent pro-apoptotic proteins of
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PML-NBs may lead cells into apoptosis. It is still unknown whether Metnase can compensate for
Artemis deficiency in resolving residual DSBs though current evidence suggests that such a
possibility may not exist due to differences in substrate requirements and differing partnerprotein interactions. However, expression of WT Metnase in CJ179 (Artemis null cell lines) cells
followed by exposure to ionizing radiation may clarify whether Metnase can replace Artemis in
the NHEJ sub-pathway for repair of DSBs showing a slow-repair kinetics.
Clinically, radiation along with concomitant chemotherapy is the mainstay for therapeutic
intervention of many types of cancer and the most clinically significant lesions resulting from
such therapy are DNA DSBs that often bear chemically modified end-termini, most commonly a
3ʹ-PG moiety. The ability of cancer cells to recognize and remove such cytotoxic DNA damage
by employing DNA repair pathways like NHEJ plays a key role in resistance to
radio/chemotherapy (Helleday et al. 2007, Helleday et al. 2008). Thus inhibitors of DNA repair
may improve the therapeutic efficacy when used in combination with radiation or other DNA
damaging agents. An ATM inhibitor developed by KUDOS pharmaceuticals (KU55933) is
already being tested for radiosensitizing glioblastomas. Several DNA-PK inhibitors have also
been developed (NU7441, KU57788)
But DNA repair pathways are highly complex, mutually collaborative, and
interconnected. A given DNA lesion can be processed through multiple redundant repair
pathways (multiple NHEJ pathways exist, see Fig. 6-1) and a single DNA repair protein may
resolve different kinds of DNA lesions (Artemis can process 3ʹ-PG ends and 8-oxoguanine
residues, APE1 functions in BER and alt-NHEJ). Removal of the 3ʹ-blockade is an essential step
in DSB repair by NHEJ that could be manipulated as a potential target for improving therapeutic
index of the currently available radiotherapeutic regimen (Dexheimer et al. 2008). The exclusive
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requirement of Artemis for repair of ~20% DNA DSB (presumably heterochromatic or complex
DNA damage) following radiation exposure leading to 2-3 fold increase in radiosensitivity on
Artemis deficiency makes it an ideal target for development of inhibitors which could be used as
radiosensitizers. However the crystal structure of Artemis is yet unknown precluding targeted
development of inhibitors for the protein. This thesis demonstrates complete loss of Artemis
endonucleolytic activity on mutation of a single asparatic acid residue at 165 position to
asparagine (D165N). Expression of the D165N protein fails to rescue the repair defect and
restore survival in Artemis deficient cells exposed to ionizing radiation or radiomimetic
chemotherapeutics. Since the D165N residue is not present in the available crystal structures of
other metallo-β-lactamase family of proteins, but is indispensable for Artemis endonuclease
function, it may be a good target for development of Artemis inhibitors. However, Artemis is
essential for V(D)J recombination and antibody diversity. This constitutive Artemis function will
need to be considered before any therapeutic drug development can occur. But if Artemis
inhibition were restricted to a short time period before and after irradiation, effects on overall
immunity would be minimal. Moreover, it is unknown if the cells can eventually compensate for
the loss of protein by overexpressing other candidate nucleases like Metnase. Thus, more work
for a better understanding of the various functions of NHEJ proteins and inter-relationships
between various NHEJ pathways is essential before further clinical development for achievement
of the desired therapeutic outcome.
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